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ABSTRACT 
Ada Al-Qunaibet: Arterial Stiffness and Peripheral Arterial Disease as Indicators of Ab-
dominal Aorta Diameters: The Atherosclerosis and Risk in Communities Study  
(Under the direction of Gerardo Heiss) 
Background: Abdominal aorta (AA) dilatation (AAD) and aneurysms result from re-
modeling that includes atherosclerotic and arteriosclerotic components. The latter frequently 
coexist across different arterial territories. Peripheral arterial disease (PAD) is an ischemic 
manifestation of atherosclerosis, while arterial stiffening (AS) primarily reflects arteriosclero-
sis. Our aim was to examine PAD and AS as potential indicators of AAD. Methods: Cross-
sectional analysis of data from the 5th examination of the Atherosclerosis Risk in Communi-
ties cohort (2011-2013). 4,802 participants 70-89 years were included to examine the asso-
ciation between PAD and AAD, and 4,224 participants were included to examine the asso-
ciation between AS and AAD. The anterior-posterior (AP) diameter of the AA was quantified 
by b-mode ultrasound at the proximal, mid-, and distal locations. The ankle-brachial index 
(ABI) and pulse wave velocity (PWV) were used to evaluate PAD and AS (central and pe-
ripheral), respectively. Heart-carotid (hc) and carotid-femoral (cf) PWV were used to quantify 
central AS, and femoral-ankle (fa) PWV was used to measure peripheral AS. ABI and PWV 
measurements were performed using an automated non-invasive waveform analyzer.  
Results: Sixty percent of examinees were women, ~22% were black, and the mean 
age was 75.3±5.1 years. The mean AP diameters and confidence intervals (CIs) for proxi-
mal, mid-, and distal diameters were; 1.95±0.32cm, 1.81±0.33cm, and 1.70±0.35cm, respec-
tively. The mean value and CI for the lowest ABI of the right and left leg was 1.10±0.14. The 
mean values and CIs for hcPWV, cfPWV, right faPWV, and left faPWV were 
1,132.8±344.5cm/s, 1,159.5±302.7cm/s, 1,099.2±180.8cm/s, and 1,067.8±174.8cm/s, re-
iv 
spectively. A U-shaped association between ABI and AAD was observed at all three levels 
of the AA. A positive, linear association between hcPWV was observed at all the levels of 
the aorta as the only measure of AS exhibiting a consistent and statistically significant asso-
ciation with AAD.  
Conclusions: In older adults AAD is associated with PAD and with central AS. Alt-
hough statistically significant, these associations are of small magnitude and have little prac-
tical applicability as indicators of AA dilatation. 
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INTRODUCTION  
The proposed doctoral research related the main features of atherosclerosis, namely 
atherosis and sclerosis, to abdominal aorta diameters and aortic aneurysms in a biracial co-
hort of 6,538 men and women aged 72-84 years. The atherotic component was indexed by 
the presence of lumen-occupying atherosclerotic lesions in the lower extremities, identified 
non-invasively by a reduced ankle-brachial index (ABI). The sclerotic element was meas-
ured by pulse wave velocity (PWV) in the central and peripheral arterial territories. The ab-
dominal aorta diameter (AAD) that served as the dependent variable was statistically pre-
dicted cross-sectionally from the above-referenced measurements.  
The dissertation focused on abdominal aorta diameters measured by abdominal ul-
trasound as the dependent variable. The first aim characterized the relationship between 
peripheral artery disease (PAD) measured by ABI and diameters of the abdominal aorta at 
proximal, mid-, and distal locations. A second aim characterized the relation between central 
arterial stiffness (measured by heart-carotid pulse wave velocity), peripheral arterial stiffness 
(measured by femoral-ankle pulse wave velocity), and the diameters of the abdominal aorta 
at a proximal, mid-aorta, and distal locations. The third aim was to develop and evaluate a 
statistical predictive model that utilizes ABI and PWV to classify AAD at clinically meaningful 
levels. 
The clinical entities pertinent to the measurements mentioned above were abdominal 
aortic dilatation and aneurysms diagnosed by abdominal ultrasound, PAD diagnosed by 
ABI, and central and peripheral arterial stiffness measured by heart-carotid pulse wave ve-
locity (hcPWV) and femoral-ankle pulse wave velocity (faPWV), respectively.  
2 
The associations hypothesized under each aim were characterized across the full spectrum 
of the study measurements and we considered pre-defined clinical cut points as secondary 
aims in order to quantify subclinical processes and to describe the pathways that lead to 
clinical disease.  
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CHAPTER 1: BACKGROUND  
1.1. Atherosclerosis   
1.1.1. Pathophysiology of atherosclerosis  
Structural components of the wall of medium and large arteries 
The arterial wall is made up by three main layers (figure 1); tunica intima, tunica me-
dia, and tunica adventitia from the lumen outward (Lâevy & Tedgui, 1999; Lusis, 2000; 
Safar, Levy, & Struijker-Boudier, 2003). The biological mechanisms of atherosclerosis are 
caused by molecular and cellular processes that mainly affect the intimal layer of arterial 
vessels (Stary et al., 1992). The tunica intima is the innermost layer that is adjacent to the 
arterial lumen. It is separated from the adjacent tunica media by the internal elastic lamina.  
Tunica intima: The tunica intima is composed of two layers; the innermost layer is 
comprised of connective tissue called proteoglycan, and the outer layer is comprised of 
smooth muscle cells and elastic fibers. Variations in blood flow strength and wall tension af-
fect the tunica intima, resulting in physiological changes that cause thickening of this struc-
ture (Stary et al., 1992). Therefore, the arterial segments with disturbed blood flow and ab-
normal laminar sheer stress, such as branching points and bifurcations in the arterial tree, 
are more prone to develop atherosclerosis (Libby, 2000; Stary et al., 1992).   
The endothelial cells that form the endothelium are the innermost layer of the tunica 
intima, which is adjacent to the arterial lumen (Stary et al., 1992). Normally endothelial cells 
do not promote the adherence of platelets or leucocytes, nor do they facilitate thrombosis 
(Stary et al., 1992). On the contrary, normal endothelium exerts the first protective anti-
atherogenic process (Gouverneur, Berg, Nieuwdorp, Stroes, & Vink, 2006; Lusis, 2000; 
Stary et al., 1992).   
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Tunica media: The tunica media constitutes the thickest layer, and its constituents 
are smooth muscle cells that secrete elastin and collagen proteins. The ratio of elastin to 
collagen varies along the arterial tree (Lâevy & Tedgui, 1999). Large elastic arteries more 
proximal to the heart contain more elastin compared to collagen, while more distal to the 
heart the ratio is reversed. A threshold point in this respect is found near the diaphragm 
where the abdominal aorta begins (Safar et al., 2003). The tunica media of muscular arter-
ies is predominantly made up of smooth muscle cells with less elastin and connective tissue. 
Therefore, medium muscular arteries are capable of changing their diameter under neuro-
humoral stimulation (Lâevy & Tedgui, 1999).  
Tunica adventitia: The tunica adventitia is primarily made up of connective tissue that 
contains collagenous fibers, elastic fibers, fibroblasts, and macrophages. From the luminal 
side, the tunica adventitia is lined by the external elastic lamina; the lateral side is less de-
fined and is in conjunction with the perivascular connective tissue (Lâevy & Tedgui, 1999).  
The adventitia is made of fibroblasts and few elastic fibers. The adventitia contains the vasa 
vasorum, which supplies nutrients and oxygen to the tunica adventitia and tunica media. In 
addition, the tunica adventitia contains a lymphatic and nervous system that supplies both 
tunica adventitia and media (Lâevy & Tedgui, 1999).   
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Definition of atherosclerosis  
Atherosclerosis is defined as a systemic disease process, and inflammatory changes 
are part of its pathophysiology. Fatty deposits, inflammatory cells, and scar tissue build up 
within the sub-intimal space of arteries (Libby, 2000; Ross, 1999). Atherosclerotic changes 
affect primarily large and medium-sized elastic and muscular arteries (Ross, 1999). Inflam-
matory, molecular, and cellular processes that mainly affect the intimal layer of arterial ves-
sels are involved in the biological mechanisms of atherosclerosis (Ross, 1999; Stary et al., 
1992). Worldwide, cardiovascular morbidity and mortality are predominantly attributed to the 
sequelae of atherosclerosis (Go et al., 2013).  
Below we combine the typology of the levels of atherosclerosis with the description 
of the dynamic process involved in atherogenesis.  
  
Figure 1. Arterial wall structure. 
 
Source:http://www.hwcrc.org/Health/illustrations%20of%20hu
man%20anatomy/Photos/arterial%20anatomy.jpg 
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Stages and types of atherosclerosis  
Atherosclerosis starts in the peripubertal life epoch and progresses through stages, 
typically identified as initiation, progression, and complication (Libby, 2000; Scott, 2002; 
Stary et al., 1994). Atherosclerotic lesions have been systematized according to their cellu-
lar components and pathophysiological progression of the disease into six types. The initial 
and intermediate lesions include types I, II, and III. Advanced atherosclerotic lesions are 
subdivided into 3 types: IV, V, and VI (Stary et al., 1992; Stary et al., 1995; Stary et al., 
1994). Of the aforementioned, types I and  II are the only two that can exist in children 
(Stary et al., 1994).  
 Initial and intermediate atherosclerotic lesions: Type I (fatty streaks) — Fatty streaks 
are microscopic lipid deposits in the intimal layer that represent adaptive changes rather 
than an atherosclerotic transformation. Lipid is deposited in macrophages in an isolated 
manner forming foam cells (macrophages that contain lipid molecules). This type of lesion is 
common among children and young adults (Stary, 1994; Stary et al., 1994).  
Type II — Type II lesions contain more abundant foam cells that are arranged in a 
stratified manner, and they are sub-grouped according to their progression into advanced 
lesions into type IIa (advanced-lesion prone) and type IIb (advanced-lesion resistant). Type 
II lesions contain some isolated mast cells, T lymphocytes, and small quantities of lipid drop-
lets in extracellular spaces. However, the number of mast cells and T lymphocytes is less 
than the number of macrophages (Katsuda, Boyd, Fligner, Ross, & Gown, 1992; Munro, van 
der Walt, Munro, Chalmers, & Cox, 1987; Stary, 1990, 1994; Stary et al., 1994). Type II le-
sions involve deposition of lipid droplets in macrophages and smooth muscle cells, as com-
pared to type I lesions which only involve lipid droplets in macrophages. Type II lesions may 
be visible as yellow spots or patches when they contain fatty streaks. Most of the lipid is de-
posited in foam cells, and small amounts are deposited in the extracellular space. Around 
three quarters of the lipid molecules in type II lesions are cholesterol esters. Development 
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and progression of type II lesions usually occurs in commonly susceptible parts of the arteri-
al tree. Mechanical forces in these susceptible parts of the tree cause an influx of plasma 
lipoproteins (Cornhill, Herderick, & Stary, 1990; Glagov, Zarins, Giddens, & Ku, 1988; Stary 
et al., 1994). Common locations for type II lesions include: coronary arteries, aortic arch, de-
scending thoracic aorta, and abdominal aorta. Only a small subgroup of type II (progression-
prone IIa) lesions progress to type III lesions in the absence of elevated harmful lipoproteins. 
Conversely, progression of type IIb (progression-resistant) lesions may not occur, and it 
takes a longer lag time and higher levels of harmful lipoproteins to occur.  In the aorta, the 
progression of type II lesions commonly occurs in the posterolateral walls (left and right) and 
at common iliac arteries bifurcation (Stary et al., 1994).  
Type III —Type III lesions are the intermediate lesions between type II and athero-
ma; they are also called transitional lesions. Histologically, type III lesions exhibit the pres-
ence of extra-cellular lipid droplets infiltrating the layers of smooth muscle cells. This infiltra-
tion interrupts the unity of the smooth muscle cells present in the intimal layer (Stary et al., 
1994).  
Advanced atherosclerotic lesions: Based on histological characteristics, advanced 
atherosclerotic lesions are subdivided into three types; IV, V, and VI. Atherosclerosis mor-
bidity and mortality is mostly due to complicated type IV and type V lesions, transforming 
them into type VI lesions. Changes in advanced atherosclerotic lesions cause disfiguration 
of the arterial wall due to intimal thickening and repair. These changes will consequently 
cause narrowing of the arterial lumen (Stary et al., 1995).  
 Type IV (atheroma) — Type IV atherosclerotic lesions are also known as atheroma. 
Lipid accumulation in type IV lesions can be recognized microscopically as a distinct area 
within the tunica intima, which is called a lipid core, and this causes intimal disarrangement 
(figure 2). The lipid core is separated from the arterial lumen predominately by a normal in-
timal endothelial surface. Type IV lesions develop where eccentric adaptive intimal thicken-
8 
ing commonly occurs. Therefore, atheroma originally exists as an eccentric lesion (Stary et 
al., 1992; Stary et al., 1995), and at this stage the arterial lumen is preserved with no evident 
stenosis (Glagov, Weisenberg, Zarins, Stankunavicius, & Kolettis, 1987; Stary et al., 1992). 
Cellular and morphologic changes that occur include: elongation of smooth muscle cells, 
thickening of their basement membranes, and calcium deposits. In addition, there is new 
capillary formation, proteoglycans, foam cells, and macrophages primarily at the lipid core 
margins. Type IV lesions, compared to type V lesions, contain less collagen and fibrous tis-
sue (Stary et al., 1995).  
 
 
Figure 2. Atheroma formation and complications. 
Source: http://www.rayur.com/wp-content/uploads/2012/06/Atheroma.jpg 
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Type V — In type V lesions there is additional fibrous connective tissue formation, 
which causes more evident narrowing of the arterial lumen. Cellular and morphologic 
changes that occur include: collagen accumulation, smooth muscle cells containing rough-
surfaced endoplasmic reticulum, and larger and more numerous capillaries. In this ad-
vanced type of atherosclerotic lesion, there is involvement of the tunica media and adventitia 
in the form of accrual of foam cells, macrophages, and lymphocytes. Type V lesions are 
prone to complications that include hematoma, fissures, and/or thrombus formation. Type V 
lesions are further subdivided by cellular variations into types Va, Vb, and Vc (Stary et al., 
1995).  
Type Va is also called a fibroatheroma; it may be multi-layered, containing more than 
one lipid core that may form in more than one dimension. The multi-directional lipid core 
formation causes narrowing of the arterial lumen. Commonly the lipid core furthest from the 
tunica intima will form first. Multiple lipid core formations and fibrosis can be the result of a 
complicated initial lipid core caused by hematoma, fissure formation, or thrombosis followed 
by fibroses and further accumulation of foam cells and lipids (Stary et al., 1995). Type Vb is 
similar to Va, however it contains more calcification and mineral deposition. Type Vc con-
tains more fibrotic tissue, and in this subtype fibrotic convective tissue replaces the normal 
tunica intima (Stary et al., 1995).  
Type VI (complicated lesions) — Hematoma, fissures, and/or thrombosis are compli-
cations that occur in type IV and type V, changing them into type VI lesions, and they are 
subdivided depending on the complications that occur. Type VIa, is a complicated lesion 
due to fissure formation, ulcer formation, or discontinuity of the surface of the atherosclerotic 
lesions. Type VIb is an atherosclerotic lesion that developed hematoma or hemorrhage. 
Type VIc is a thrombotic atherosclerotic lesion. The coexistence of all of these three compli-
cations is called type VIabc atherosclerotic lesion (Stary et al., 1995).  
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Natural history of atherosclerosis: As mentioned previously, atheromatous lesions 
may develop morphological complications that include hematomas, fissures, ulcers, and 
thrombosis (Stary et al., 1995). Complicated atherosclerotic changes lead to subclinical cen-
tral changes, most commonly coronary artery calcification (CAC) and carotid intima-media 
thickening (CIMT). Other lesions include renal artery stenosis (RAS) and peripheral artery 
disease (PAD). Atherosclerosis is a progressive disease that commonly affects various arte-
rial beds. Therefore the aforementioned subclinical atherosclerotic manifestations frequently 
coincide (Go et al., 2013; Imori et al., 2014). The progression and complications of athero-
sclerosis depend on the severity and location of the lesion and trigger factors.  
1.1.2. Clinical implications of atherosclerosis  
Clinical manifestations  
The main clinical manifestations of atherosclerosis include coronary heart disease 
(CHD), myocardial infraction (MI), and stroke.  
Methods to assess acute, clinical manifestations atherosclerosis  
Clinical signs and symptoms are commonly used to assess clinical manifestations of 
atherosclerosis, with the aid of a number of methods used to confirm the diagnosis. The lat-
ter include electrocardiogram (ECG), cardiac biomarkers, computed tomography (CT), and 
magnetic resonance imaging (MRI) (Anderson et al., 2011). The clinical manifestations of 
atherosclerosis and their measurement in different arterial territories and target organs are 
outside the scope of this research and will not be developed here. 
Epidemiology  
Population distribution of atherosclerosis 
Atherosclerosis is a chronic process that starts early in life. The coexistence of more 
than one atherosclerotic manifestation is not uncommon. The abdominal aorta, coronary ar-
teries, internal carotid, and popliteal arteries are sites of predilection for atherosclerosis. Ma-
11 
jor complications due to atherosclerotic changes in the aforementioned arterial territories 
include CHD, MI, stroke, PAD, and abdominal aortic aneurysms (AAAs) (Go et al., 2014).  
It is estimated that at least one in three Americans has one type of cardiovascular 
disease, and a little over half of the cases affect adults sixty years of age or older (Go et al., 
2014). Age-standardized death rates due to cardiovascular disease are estimated to have 
decreased by 1.1% per year for males and 1.25% per year for females during the last two 
decades, although due to an aging population the total number of deaths is projected to in-
crease by 6.6 million from 2002 to 2030. In 2002, ischemic heart disease (IHD) and cere-
brovascular disease were ranked as the first and second leading causes of death and the 
sixth and seventh leading causes of disability-adjusted life years (DALY’s) globally. They are 
projected to remain the first two leading causes of death in 2030, and to move up to the third 
and sixth leading causes of DALY’s globally (Mathers & Loncar, 2006). 
Coronary heart disease (CHD) 
The overall prevalence of CHD in U.S. adults twenty years or older is 6.4%, extrapo-
lated from the National Health and Nutrition Examination Survey (NHANES) 2007-2010 data 
(NHLBI tabulation), and CHD prevalence is projected to increase 18% by 2030 (Heidenreich 
et al., 2011). In 2010 alone, the prevalence of CHD was estimated to be 15.4 million, and in 
2014 it is estimated that 620,000 Americans will have a new coronary attack (Go et al., 
2014). 
Myocardial infarction (MI) 
The overall prevalence of MI in U.S. adults twenty years or older is 2.9% (extrapolat-
ed from NHANES (2007-2010 data, NHLBI tabulation) (Heidenreich et al., 2011).  It is esti-
mated that the prevalence of MI was 7.6 million in 2010 and the American Heart Association 
(AHA) estimates that in 2014 one American will have an attack of MI every forty four sec-
onds (Go et al., 2014). 
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Stroke  
The prevalence of stroke in the United States is estimated at 2.8% (using NHANES 
data 2007-2010) (Go et al., 2014). The AHA projects an overall increase of 20% in the prev-
alence of stroke by the year 2030 (Ovbiagele et al., 2013). The projected increase is fore-
seen to affect men, women, and all ethnic groups (Ovbiagele et al., 2013).  Approximately 
795,000 individuals experience a stroke; 76.7% are a first attack, 23.3% are a recurrent at-
tack, and 87% of strokes are due to ischemia (Go et al., 2013). The population distribution of 
stroke is affected by gender, age, and ethnicity (Go et al., 2013).  
Risk factors  
Atherosclerosis is a multifactorial disease, and various risk factors are involved to 
varying degrees in its development and complications. Well-established and widely replicat-
ed risk factors for atherosclerosis include both modifiable and non-modifiable factors. Modi-
fiable risk factors include elevated blood pressure, cigarette smoking, diabetes mellitus, and 
abnormal lipid levels. Non-modifiable risk factors include aging, gender, and family history 
(Go et al., 2014). 
Elevated blood pressure  
It is estimated that almost eighty million Americans suffer from elevated blood pres-
sure (Go et al., 2014). It is significantly associated with atherosclerotic lesions (Solberg & 
Strong, 1983) and is a strong determinant of stroke (Go et al., 2014). According to estimates 
from a number of NHLBI studies, around three quarters of first stroke attacks occur in indi-
viduals with blood pressure levels over 140/90 mmHg (Go et al., 2014).  
Cigarette smoking  
Cigarette smoking is positively and significantly associated with atherosclerotic le-
sions (especially in the aorta and peripheral arteries) (Solberg & Strong, 1983; Zieske, 
Malcom, & Strong, 2002). The association is dose-response in nature, and it is estimated 
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that the risk of stroke in current smokers is 2-4 times the risk of stroke in non-smokers and 
quitters (Bhat et al., 2008; Goldstein et al., 2011; R. S. Shah & Cole, 2010).  
Diabetes mellitus  
 Diabetes mellitus is a strong risk factor for atherosclerosis. There is a parallel in-
crease between the increase in diabetes prevalence and cardiovascular morbidity and mor-
tality (Go et al., 2013; Wilsgaard & Jacobsen, 2007). Diabetic adults have 2-4 times the rate 
of developing heart disease compared to non-diabetics, and they have higher morbidity and 
mortality due to cardiovascular disease (US Department of Health and Human Services, 
Centers for Disease Control and Prevention; 2011) (Donahoe et al., 2007).  
Hyperlipidemia  
Hypercholesterolemia is the more prominent component of hyperlipidemia affecting 
atherosclerosis. The degree and level of association of HDL, total cholesterol, and triglycer-
ide are inconsistent (de Boer et al., 2011; Go et al., 2013; Solberg & Strong, 1983; Zieske et 
al., 2002).   
Gender  
 Atherosclerotic changes and manifestations are generally more common in men (Go 
et al., 2014). An example of subclinical atherosclerosis difference due to gender is that seen 
in CAC prevalence. The prevalence of CAC among women and men between 33 and 45 
years of age is 5.1% and 15%, respectively (Loria et al., 2007). The prevalence is reported 
to be much higher in cohorts that include older ages, reaching 32% for women and 52.9% 
for men (Hoffmann, Massaro, Fox, Manders, & O'Donnell, 2008).  CHD and MI prevalence 
are higher in men. CHD prevalence in U.S. adults is 5.1% in women and 7.9% in men, and 
the prevalence of MI is 1.7% in women and 4.2% in men (Go et al., 2014).  
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Family history  
 Family history of atherosclerotic cardiovascular disease reflects the interplay be-
tween biologically similar genetics and/or similar unhealthy environmental attributes. Both 
may act synergistically in increasing the risk of atherosclerotic morbidity and mortality. Cap-
turing genotype and phenotype links using genome-wide association has been able to elicit 
small effects (Go et al., 2014).  
  In the U.S., positive family history for heart attack or angina is approximately 12.6%, 
with the highest reported prevalence seen in non-Hispanic white males and females (Go et 
al., 2014). A history of MI in parents increases the odds of having an MI: A history of MI in a 
single parent 50 years or older increases the odds of having an MI to 1.67 compared to 
those without parental history. Having a positive family history of MI in both parents at the 
age of 50 years or older increases the odds ratio to 2.36, and the odds ratio more than dou-
bles if both parents had an MI before the age of fifty years (Chow et al., 2011).    
1.1.3. Subclinical atherosclerosis  
Topographical distribution of atherosclerosis 
CAC, CIMT, RAS, and PAD have been identified as topographical manifestations of 
atherosclerosis.  
Coronary artery calcification 
Calcium deposits are integral to the atherosclerotic process, and artery calcification 
is pathognomonic of atherosclerosis. Calcific deposits in the coronary arteries can been 
seen using electron beam and/or helical computed tomography (CT) (Wexler et al., 1996). 
Calcification offsets arterial enlargement of the atherosclerotic coronary arteries (Clarkson, 
Prichard, Morgan, Petrick, & Klein, 1994). CAC in itself is not evident clinically, and it is a 
weak predictor of plaque rupture (Richardson, Davies, & Born, 1989). The portion of the 
CAC lesion most vulnerable to rupture is the connecting shoulder between the calcific cap 
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and the intima. Clinical manifestations occur due to plaque rupture or severe coronary artery 
narrowing (Wexler et al., 1996). 
Carotid intima media thickening  
Because of ease of accessibility, CIMT is commonly used to quantify atherosclerotic 
burden and to measure the progression of atherosclerosis. CIMT is believed to develop be-
fore CAC lesions (Go et al., 2013; Hodis et al., 1998). CIMT is commonly measured using B-
mode ultrasound, which measures the tunica intima and tunica media layers of the carotid 
arteries (Go et al., 2013).  
Methods to assess subclinical atherosclerosis 
 Non-invasive measures are used to visualize atherosclerosis that is subclinical or 
did not yet manifest. Computed tomography of the chest and B-mode ultrasound are used to 
assess CAC and CIMT, respectively (Go et al., 2014).  
Epidemiology  
Prevalence of subclinical atherosclerosis  
The chronicity of atherosclerosis development and the advancement in imaging 
technology has promoted the examination of the level of atherosclerotic changes in the arte-
rial systems to assess the burden of subclinical atherosclerosis. CAC and CIMT represent 
central subclinical atherosclerosis, and they are evaluated using chest computed tomogra-
phy and B-mode ultrasound, respectively.  
Coronary artery calcification  
The prevalence and progression of CAC have been examined in populations of vary-
ing demographics. The prevalence of CAC varied according to age, gender, ethnicity, and 
cardiovascular risk factors, and it progressed more slowly with a healthy life style (Ahmed et 
al., 2013; Budoff et al., 2013). The prevalence of CAC in the Coronary Artery Risk Develop-
ment in Young Adults (CARDIA) study, a U.S.-based cohort of young adults, was reported to 
be 9.6% in adults, three times the prevalence in men compared to women, one-and-a-half 
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times the prevalence in whites compared to African Americans, and twice the prevalence in 
adults between the ages of forty and forty five years compared to adults between the ages 
of thirty three and thirty nine years of age (Loria et al., 2007).  
Carotid intima-media thickening  
CIMT is the measurement of the intima and media layers of the carotid arterial wall. It 
is commonly measured with B-mode ultrasound, which also can assess arterial narrowing 
and plaque formation (Go et al., 2014). B-mode ultrasound is a reliable and valid tool ("High-
resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities 
Study (ARIC). The ARIC Study Group," 1991) that has been used by large U.S. observa-
tional studies to quantify CIMT (Bots, Vanmeurs, & Grobbee, 1991; Budoff et al., 2013; 
Chambless et al., 1997; Heiss et al., 1991). CIMT is a surrogate for and indicator of general-
ized atherosclerosis (Bots et al., 1991), and it is considered a predictor of CAD (Chambless 
et al., 1997).  
The Bogalusa Heart Study (S. Li et al., 2003; Urbina et al., 2002) and the NHLBI’s 
Cardiovascular Heart Study (O'Leary et al., 1999) are just two of the studies that have ex-
amined the prevalence of CIMT.  In these studies it has been observed that CIMT is more 
severe in the presence of cardiovascular risk factors. According to epidemiological studies, 
CIMT is considered high-risk if the thickness equals or exceeds 1 mm or if it lies in the high-
est quartile or quintile according to age and gender (Go et al., 2014).  
Risk factors  
 Subclinical and clinical atherosclerosis have common predisposing risk factors, and 
they are mentioned above in sections B.1.2. and B.1.3. Early exposure to modifiable risk 
factors increases the risk of subclinical atherosclerosis and consequent development of clin-
ical complications (Berry et al., 2009; Loria et al., 2007).   
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1.2. Peripheral arterial disease  
PAD involves atherosclerotic changes of the wall of arteries supplying the visceral 
organs and limbs (Hirsch et al., 2006). The presence of atherosclerotic changes in one 
segment of the arterial system is likely associated with atherosclerotic changes in other 
parts of the arterial tree. Therefore, individuals with PAD have a higher risk of developing 
ischemic events resulting in higher morbidity and mortality (Hirsch et al., 2006). 
PAD is defined as insufficient arterial flow to the periphery due to atherosclerotic oc-
clusive disease (Schirmang, Ahn, Murphy, Dubel, & Soares, 2009). Being effected with PAD 
reduces the quality of life, and studies have shown that modifying risk factors improves mor-
bidity and mortality due to PAD (Abdulhannan, Russell, & Homer-Vanniasinkam, 2012). In-
termittent claudication is muscular pain and/or cramps triggered by an increase in oxygen 
demand at the extremities that exceeds the available oxygen response and represents the 
hallmark of PAD manifestations (Abdulhannan et al., 2012). Intermittent claudication is in-
sensitive as a tool to identify PAD in populations at higher risk for PAD, e.g., older popula-
tions and those with an elevated burden of risk factors (such as smoking and diabetes melli-
tus). Approximately 48% of newly diagnosed PAD individuals do not report leg pain, 46% 
report atypical leg pain, and only 5.5% report classic claudication; it is estimated that 85-
95% of PAD cases would be missed if clinicians mainly relied on clinical symptoms (Hirsch 
et al., 2001; McDermott et al., 2001).  
The first line to establish a diagnosis of PAD is commonly the ankle-brachial index 
(described below). However, duplex ultrasound is the recommended diagnostic tool to es-
tablish the need for intervention (Layden, Michaels, Bermingham, Higgins, & Guideline 
Development, 2012).  
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1.2.1. Methods to measure peripheral artery disease 
A number of diagnostic tools are available to measure PAD, including invasive and 
noninvasive tools, as shown in Appendix 1.  
Ankle-brachial index 
Ankle brachial index—the ratio of the ankle over the brachial systolic pressures—is a 
non-invasive measurement of documented high sensitivity and validity in the assessment of 
peripheral arterial occlusive disease. Lower levels of ABI also are associated with central 
atherosclerotic changes, including subclinical atherosclerosis in other vascular territories 
such as coronary artery disease, incident ischemic strokes, and recurrent strokes (Feringa 
et al., 2007; A. J. Lee et al., 2004; McDermott et al., 2005; Otah et al., 2004; Papamichael et 
al., 2000; Resnick et al., 2004; Tsai, Folsom, Rosamond, & Jones, 2001; Zheng et al., 
1997). A strong inverse association between ABI categories and ischemic strokes exists. 
However, the strength of association is driven by the presence of common cardiovascular 
risk factors (Tsai et al., 2001). Furthermore, ABI has been shown to aid in identifying per-
sons with moderate to high cardiovascular risk and to be a predictor of cardiovascular mor-
bidity and mortality (A. J. Lee et al., 2004; Papamichael et al., 2000; Resnick et al., 2004).  
Definition and values 
The systolic blood pressure progressively increases as the blood flows distally from 
the heart, resulting in a higher systolic blood pressure level at the ankle than that measured 
in the brachial artery. This is known as blood pressure amplification (Nichols, Nichols, & 
McDonald, 2011). The ratio of the systolic ankle blood pressure to the brachial systolic blood 
pressure provides the ABI (Aboyans et al., 2012), which was initially described by Winsor in 
the last century (Winsor, 1950).   
An ABI value in the range between 1.00 and 1.29 is considered normal, while ABI 
values above 1.30 imply non-compressible arteries. ABI levels of 0.90 and less indicate re-
duced arterial supply to the lower extremity. Values between 0.41 and 0.90 suggest mild to 
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moderate diminution of arterial supply, and ABI values equal to or less than 0.40 indicate 
severely diminished arterial supply (Hirsch et al., 2006; Rooke et al., 2011).  
Factors affecting ABI measurement  
ABI measurement can be affected by procedural factors and by individual physiolog-
ical factors (Aboyans et al., 2012). Some of the technical factors that affect ABI measure-
ment include incorrect cuff size, using a spiral versus a parallel cuff wrapping method, and 
measuring systolic ankle blood pressure in the sitting position (60, 63-65). Adherence to pro-
tocol is thus essential to limit procedural factors affecting ABI measurement.  
Physiological factors related to the patient that can affect ABI measurement include 
height, gender, heart rate, ethnicity, and having smoked ten minutes prior to ABI measure-
ment (Aboyans et al., 2007; Bird et al., 1999; London, Guerin, Pannier, Marchais, & Stimpel, 
1995; F. B. Smith, Lee, Price, van Wijk, & Fowkes, 2003; Su et al., 2007; Zheng et al., 
2005).  
1.2.2. Epidemiology of lower extremity PAD 
Prevalence and incidence 
The prevalence of lower extremity PAD is high in older populations and among indi-
viduals exposed to risk factors. In 2000, the prevalence among American adults aged 40 
years and older was 8.5 million, and PAD was estimated to affect 7.2% of the U.S. popula-
tion at that time (Allison et al., 2007).   The incidence of PAD in the same age range is esti-
mated to be 2.35% per year (using a sample of insurance claims in the U.S.) (Nehler et al., 
2014). A retrospective cohort analysis conducted between 2003 and 2008 utilizing insurance 
claims in the U.S. estimated the mean annualized prevalence and incidence of lower ex-
tremity PAD among adults to be approximately 10.7% and 2.35%, respectively (Nehler et 
al., 2014). Prevalence and incidence estimates vary among different studies and popula-
tions. In the Framingham study, a higher incidence of lower extremity PAD was related to 
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older age and the presence of atherosclerosis risk factors (Kannel & McGee, 1985; Murabito 
et al., 2002a).  
Morbidity and mortality 
Age-standardized death rates for peripheral vascular disease in 2010 were 0.7 per 
100,000, which has increased by 53% since 1990 (Lozano et al., 2012). In 1990 DALY’s for 
peripheral vascular disease was 14 per 100,000; it has increased by 51.7% since then 
(Murray et al., 2012). Years lived with disability from peripheral vascular disease in 2010 
was 6 per 100,000, representing an increase of 26.0% since 1990 (Vos et al., 2012).  
1.2.3. Risk factors for peripheral artery disease  
PAD is caused by peripheral atherosclerosis. As a result, PAD is affected by the 
aforementioned risk factors of atherosclerosis, particularly cigarette smoking and diabetes 
mellitus, which are the strongest risk factors affecting lower-extremity PAD (Criqui, 
Denenberg, Langer, & Fronek, 1997; Go et al., 2014; Hirsch et al., 2006).  
Cigarette smoking and lower-extremity PAD are strongly associated. In approximate-
ly twenty thousand men and women, it was found that 80% of individuals with lower extremi-
ty PAD were current or ex-smokers (Fowkes et al., 1992; G. D. Smith, Shipley, & Rose, 
1990). The effect of smoking on the risk of lower extremity PAD is dose dependent (Cole et 
al., 1993; Powell et al., 1997; Price et al., 1999).  Diabetes is another well-recognized risk 
factor for lower extremity PAD. Twelve to twenty percent of individuals with lower extremity 
PAD are diabetics (Hiatt, Hoag, & Hamman, 1995; Meijer et al., 1998), and the risk of devel-
oping lower extremity PAD in diabetics is two to four times the risk in non-diabetics (Beks et 
al., 1995; Criqui et al., 1997; Hiatt et al., 1995; Meijer et al., 1998; Newman et al., 1993).   
Abnormal lipid levels are a somewhat weaker risk factor for lower-extremity PAD, 
and the strength and direction of the association varies according to different lipid subtypes. 
Increased levels of low-density lipoprotein and decreased levels of high-density lipoprotein 
are positively associated with lower extremity PAD (Fowkes et al., 1992; Hiatt et al., 1995; 
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Murabito et al., 2002b), while an inconsistent association between increased levels of tri-
glyceride and lower-extremity PAD exists (Greenhalgh et al., 1971; Mowat et al., 1997; Novo 
et al., 1992). There is an almost parallel relationship between increasing levels of total cho-
lesterol and an increase in the risk of developing lower-extremity PAD, where an increase in 
total cholesterol by 10 mg/dL increases the risk of developing lower extremity PAD by 5% to 
10% (Ingolfsson, Sigurdsson, Sigvaldason, Thorgeirsson, & Sigfusson, 1994; Murabito, 
D'Agostino, Silbershatz, & Wilson, 1997; Newman et al., 1993).  
 Elevated blood pressure is a strong risk factor for many atherosclerotic changes 
causing CAD. However, it is a weaker risk factor for lower extremity PAD (Criqui et al., 1997; 
Murabito et al., 1997; Novo et al., 1992), and the directionality and strength of the associa-
tion varies among studies (Fowkes et al., 1992; Murabito et al., 1997; G. D. Smith et al., 
1990).  
1.3. Abdominal aorta dilatation and aneurysm  
Definition 
Commonly, the AAD is defined as an AAA when the antero-posterior diameter 
measures 3 cm or more. Other plane diameters have been used, however the antero-
posterior diameter yields reproducible results and therefore it is more commonly used 
(Hirsch et al., 2006). 
1.3.1. Pathophysiology of AAD and AAA  
The abdominal aorta is a site of predilection and of early onset of atherosclerosis, 
which may lead to abdominal aortic dilatation and loss of the tapered cylindrical shape of 
this segment of the aorta. The pathophysiological processes resulting in ADD and AAA are 
complex, and although atherosclerosis plays a role in AAD and AAA, other cellular and mo-
lecular changes have been identified (Hirsch et al., 2006). In AAAs the tunica media is main-
ly involved, unlike atherosclerosis, where the tunica intima is the main arterial layer involved 
(Davies, 1998). In both atherosclerosis and aneurysmal formation, inflammatory processes 
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have been identified as part of the pathophysiological pathway. Destruction of the elastic 
lamina of the tunica media is a main histopathological feature in AAAs (Davies, 1998; Hirsch 
et al., 2006). In aneurysmal formation, inflammatory infiltrates, specifically macrophages, 
have been identified in the medial layer (Agmon et al., 2003; Davies, 1998). The inflammato-
ry process stimulates macrophages and smooth muscle cells to produce metalloproteinase 
(MMP) enzymes that degrade the elastic lamina connective tissue formed of elastin and col-
lagen (Davies, 1998; Goodall, Porter, Bell, & Thompson, 2002; Reed, Reed, Stemmermann, 
& Hayashi, 1992). The destruction in the tunica media leads to loss of elastic recoil and 
weakening of the aortic wall and consequently the inability to withstand systolic pressure.  
1.3.2. Methods to measure AAD and AAA 
Diagnostic imaging used to evaluate AAD and diagnose AAA include ultrasonogra-
phy (US), CT scanning, and magnetic resonance arteriogram (MRA) scanning. In clinical 
practice, ultrasonography is commonly used to screen and diagnose AAA. Methods such as 
CT and MRA are considered the “gold standard” radiological techniques and are used in 
pre- and postoperative evaluation (Hirsch et al., 2006; Rubin, Armerding, Dake, & Napel, 
2000). Incidental abdominal aneurysm diagnoses are not uncommon in older adults, as they 
are subject to more radiological imaging. AAAs can be detected on plain radiographs, ultra-
sound images, and CT images that are targeting other organs (Hirsch et al., 2006).   
Ultrasonography 
Ultrasonography is the least invasive and least expensive diagnostic imaging method 
used to measure AAD and diagnose AAAs. B-mode US and duplex US are both used 
(Hirsch et al., 2006). The accuracy of US in diagnosing AAAs depends on their anatomical 
location. For infrarenal aneurysms, US specificity approaches 100%, and its sensitivity is 
between 92% and 99% (Hirsch et al., 2006). The specificity and sensitivity for US consider-
ably drops, barely reaching 50%, for diagnosing suprarenal and iliac aneurysms (Hirsch et 
al., 2006; Lamah & Darke, 1999). Using duplex US can slightly improve the accuracy of de-
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tecting AAAs in the suprarenal and iliac arteries (Fillinger, 2000; Hirsch et al., 2006; Lamah 
& Darke, 1999).  
Computed tomography 
Computed tomographic imaging using contrast is the diagnostic and evaluative tech-
nique preferred by many clinicians. Contrast-enhanced CT determines the widest transverse 
diameter of the AAA and how it relates to the renal arteries, the length and caliber of the 
normal abdominal aortic segment inferior to the renal arteries, arterial disease in the adja-
cent abdominal aortic branches, and the presence of other non-arterial anomalies in the pa-
ra-aortic soft tissue (Coulam & Rubin, 2001; Papanicolaou et al., 1986). 
Magnetic resonance arteriogram     
MRA is the preferred diagnostic and evaluative technique for preoperative AAAs 
when the presence of mural calcification is suspected (Hirsch et al., 2006). MRA is more 
time consuming and expensive than CT and US.  
1.3.3. Epidemiology of AAD and AAA 
Population distribution of AAD and AAA    
The prevalence of AAAs is affected by a number of factors, which include age, gen-
der, sex, cigarette smoking, and family history. The prevalence of AAAs measuring 2.9-4.9 
cm in diameter estimated in northern European cohorts for men between 45 and 54 years of 
age is approximately 1.3%, and it increases reaching 18.5% in men between 75-84 years of 
age (Boll, Verbeek, van de Lisdonk, & van der Vliet, 1998; Go et al., 2014; Singh, Bonaa, 
Jacobsen, Bjork, & Solberg, 2001; Wilmink & Quick, 1998). The prevalence among women 
in the same age groups is almost half that seen in men. It rarely exists in women between 
45 and 54 years of age and ranges between 1% and 4.8% in women between 75-84 years 
of age (Boll et al., 1998; Go et al., 2014; Hirsch et al., 2006; Singh et al., 2001).    
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Morbidity and mortality  
From twenty one different regions of the world, DALY’s for all ages and age-
standardized DALY’s for AAAs have increased by an average of 34.6% and 3.6%, respec-
tively, from 1990 to 2010 (Murray et al., 2012). Globally, deaths attributed to aortic aneu-
rysms across all ages calculated from 187 different countries increased by 45.3% during the 
same period, while the age-standardized death rate from aortic aneurysms decreased by 
12.7% during the same period (Lozano et al., 2012). An 18-study meta-analysis was recent-
ly conducted, mostly comprised of prospective studies with a mean follow-up of 4 years 
based, on 15,475 individuals diagnosed with a small aneurysm and undergoing follow-up 
(Powell et al., 2011; Sweeting, Thompson, Brown, Powell, & collaborators, 2012). The 
pooled mean growth in the diameter of AAAs was approximately 2.21 mm/year, which did 
not vary by gender. The rate of AAA growth was significantly and consistently affected by 
smoking status and diabetes mellitus (after adjusting for medical history, drug history, and 
demographics) (Sweeting et al., 2012). Abdominal aortic aneurysms showed a faster rate of 
growth by 0.35 mm/year in current smokers compared to ex-smokers and never-smokers 
(Sweeting et al., 2012).  The presence of diabetes mellitus slowed the rate of AAA growth by 
0.51 mm in a continuous fashion (Sweeting et al., 2012).   
The rupture rates widely varied among the studies included in the meta-analysis 
(0.71/1000 person-years to 11.03/1000 person-years). The heterogeneity of rupture rates 
was attributed mainly to varying baseline AAA diameters. Higher hazard ratios for AAA rup-
ture were seen in current smokers and women—2.02 and 3.76, respectively (Sweeting et 
al., 2012). In addition, mean arterial blood pressure and pulse pressure elevation (per 10 
mmHg) were associated with a higher hazard ratio for AAA rupture—1.32 and 1.11, respec-
tively (Sweeting et al., 2012).   
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1.3.4. Risk factors  
The atherosclerosis risk factors mentioned in section B.1.2. are commonly present in 
AAA patients, with a stronger association observed with smoking, age, gender, and body 
surface area (Agmon et al., 2003; Reed et al., 1992). 
1.4. Arterial stiffness  
1.4.1. Pathophysiology of arterial stiffness 
Arterial stiffness begins early in life and is the result of progressive pathophysiologi-
cal changes that occur in the large elastic arteries; it consists of structural and cellular trans-
formations leading to reduced distensibility. Arterial stiffness is an incompletely understood 
process, and it is widely considered to be a contributor to cardiovascular morbidity and mor-
tality (Boutouyrie et al., 2002; Covic, Haydar, Bhamra-Ariza, Gusbeth-Tatomir, & Goldsmith, 
2005; Khadilkar, Chiplonkar, Pandit, Kinare, & Khadilkar, 2012; Kim et al., 2011; Laurent et 
al., 2001; Sutton-Tyrrell et al., 2005; Vlachopoulos, Aznaouridis, & Stefanadis, 2010). The 
process of arterial stiffening can be accelerated by cardiovascular risk factors, including ar-
terial hypertension (Arnett et al., 2000; Kaess et al., 2012; Laurent et al., 2003; Liao et al., 
1999), tobacco use (Doonan et al., 2010; Jatoi, Jerrard-Dunne, Feely, & Mahmud, 2007; Yu-
Jie, Hui-Liang, Bing, Lu, & Zhi-Geng, 2013), elevated plasma glucose levels (Cruickshank et 
al., 2002; Henry et al., 2003; Martens, van der Graaf, Dijk, Olijhoek, & Visseren, 2008), and 
elevated lipid levels (Urbina et al., 2013; Wang et al., 2011). 
Arterial stiffness affects large elastic arteries more than medium and small muscular 
arteries (Benetos, Laurent, Hoeks, Boutouyrie, & Safar, 1993; Gillessen, Gillessen, Sieberth, 
Hanrath, & Heintz, 1995; Lakatta & Levy, 2003; Zieman, Melenovsky, & Kass, 2005). The 
compliance of large elastic arteries is primarily maintained by secretion and degradation of 
elastin and collagen proteins (Zieman et al., 2005). Arterial stiffness develops due to dise-
quilibrium in this process and compositional changes in the arterial wall resulting in dimin-
ished amounts of normal elastin coupled with increased amounts of abnormal collagen 
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(Johnson, Baugh, Wilson, & Burns, 2001; Zieman et al., 2005).  
The structural and cellular changes in the arterial wall resulting in the development of 
arterial stiffness involve more than one layer, and some of these changes are shared in 
more than one layer. The innermost layer of the arterial wall (tunica intima) exhibits patho-
physiological changes that contribute to arterial stiffening including disorganization and ab-
normal changes of endothelial cells, increased production of abnormal collagen, breakdown 
of elastin and development of frayed elastin structure, and increased permeability causing 
infiltration of smooth muscle cells and macrophages. The changes in the middle layer of the 
arterial wall (tunica media) demonstrate changes in collagen, elastin, and smooth muscle 
cells similar to those seen in the intimal layer (Lakatta, 2003; Lakatta & Levy, 2003; Zieman 
et al., 2005). Hemodynamic forces affect these changes, and they do not occur homoge-
nously throughout the arterial tree.  
Central arterial stiffness   
 Differences in the degree of arterial stiffening occur in various segments of the aorta, 
due to inherent variability in the elasticity of the anatomical aortic segments (R. T. Lee & 
Kamm, 1994a, 1994b).  
In this dissertation we chose to include heart-carotid PWV (hcPWV) as the measure 
for central arterial stiffness (although it is not as reliable as cfPWV) in to avoid measurement 
error introduced in cfPWV estimates, which include the abdominal aorta and its dilatation 
(the dependent variable of these analyses).  
Peripheral arterial stiffness 
The peripheral arterial system is primarily composed of medium-sized muscular ar-
teries. As mentioned above, these arteries undergo slower stiffening changes than large 
elastic arteries. This can be explained in part by the inherent variability in the cellular com-
ponents and structure of peripheral arteries compared to central arteries. In young adults, 
central arteries are more elastic than peripheral arteries, i.e., the “stiffness gradient” (Latham 
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et al., 1985; Laurent, Boutouyrie, & Lacolley, 2005; Laurent et al., 2006). Reversal of the 
stiffness gradient is influenced by aging and hypertension (Benetos et al., 1993; Boutouyrie 
et al., 1992).   
1.4.2. Methods to measure arterial stiffness 
 Arterial stiffness can be assessed using various techniques and equations (Appendix 
2) (Chirinos, 2012); many of these techniques assess regional stiffness, while systemic stiff-
ness is assessed by “models of the circulation” (Laurent et al., 2006). PWV is a valid, repro-
ducible non-invasive measure of arterial stiffness (Chirinos, 2012). It has been used more 
frequently in recent studies to evaluate regional stiffness, which speak to the changes in the 
arterial wall examined (Laurent et al., 2006).  Arterial stiffness measured by PWV is de-
pendent on the arterial wall properties and the wall thickness/lumen diameter ratio. This re-
lationship is best described by the Moens–Korteweg equation, PWV=  	  , where h is wall 
thickness, E is Young’s modulus of the arterial wall, D is arterial diameter, and  
 is blood 
density(Chirinos, 2012).   
 The degree of arterial stiffness measured by PWV is currently used in clinical prac-
tice in some Asian and European countries to evaluate cardiovascular health and assess 
cardiovascular morbidity and mortality. 
1.4.3. Epidemiology of arterial stiffness  
Interest in evaluating central and peripheral arterial stiffness has grown in the past 
decade or so. Central arterial stiffness is more commonly evaluated in association with car-
diovascular outcomes than peripheral arterial stiffness (Mattace-Raso et al., 2006; Meaume 
et al., 2001; Shokawa et al., 2005; Sutton-Tyrrell et al., 2005; Willum-Hansen et al., 2006). 
However, current AHA guidelines do not list arterial stiffness as a phenotype recommended 
to estimate cardiovascular disease risk, and no conventional cut points have been proposed 
for PWV in the U.S. (Greenland et al., 2010). Arterial stiffness measured by PWV has been 
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linked to cardiovascular outcomes in a number of population-based studies (Mattace-Raso 
et al., 2006; Mitchell et al., 2010; Sutton-Tyrrell et al., 2005; Willum-Hansen et al., 2006). 
The relative risk of cardiovascular outcomes due to increased arterial stiffness is estimated 
by comparing tertiles (Mattace-Raso et al., 2006) or quartiles (Mitchell et al., 2010; Sutton-
Tyrrell et al., 2005), and in both instances, higher levels of PWV are associated with a high-
er relative risk of cardiovascular outcomes ranging from 1.25 to 3.4 (Mattace-Raso et al., 
2006; Mitchell et al., 2010; Sutton-Tyrrell et al., 2005; Willum-Hansen et al., 2006).
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CHAPTER 2: STUDY AIMS AND HYPOTHESIS 
The study aims that guided this doctoral research were stated as follows: 
 
I. Describe the distribution of AAD at proximal, mid-, and distal locations by levels of 
PAD measured by ABI at the cohort Visit 5 examination. Descriptive analyses will 
be limited to age, gender and race for the study population included in these anal-
yses.   
• Examine the distribution of peripheral artery disease by age, gender, and race.  
i. We anticipate that stratifying by age, gender, and race will elicit differences 
in the distribution of peripheral artery disease. 
• Examine the distribution of abdominal aorta diameters at proximal, mid-, and distal 
locations according to age, gender, and race   
i. We anticipate that stratifying by age, race, and gender will elicit differences 
in the distribution of abdominal aorta diameters at proximal, mid-, and distal 
locations.  
• Characterize the strength and shape of the association between ABI and ab-
dominal aorta diameters at proximal, mid-, and distal locations and across the 
range of ABI values.  
i. We hypothesize that decreasing levels of ABI will be associated with wider 
abdominal aorta diameters. 
ii. We hypothesize that the strength of association will increase from proximal 
to distal levels of the abdominal aorta.   
• Examine the role of demographic characteristics, as well as the history of cigarette 
smoking, elevated blood pressure, and type 2 diabetes as covariates and potential 
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effect modifiers of observed associations between ABI and abdominal aorta diame-
ters.  
i. We anticipate that the strength of association between peripheral artery 
disease and abdominal aorta diameters will vary due to potential confound-
ers and/or effect modifiers such as cigarette smoking, elevated blood pres-
sure, and type 2 diabetes. 
II. Describe the association of central and peripheral arterial stiffness measured by 
hcPWV and faPWV, respectively, and abdominal aorta diameters at proximal, mid-, 
and distal locations at the cohort Visit 5 examination 
• Examine the distribution of central and peripheral arterial stiffness by age, gender, 
and race.  
i. We anticipate that stratifying by age, gender, and race will elicit differences 
in the distribution of central and peripheral arterial stiffness. 
• Characterize the strength and shape of the association between (a) central arterial 
stiffness, measured by hcPWV, and abdominal aorta diameters at proximal, mid-, 
and distal locations; and (b) peripheral arterial stiffness, measured by faPWV, and 
abdominal aorta diameters at the three locations stated above.  
i. We hypothesize that increasing levels of hcPWV and faPWV will be associ-
ated with wider abdominal aorta diameters. 
ii. We hypothesize that the strength of association will increase from proximal 
to distal levels of the abdominal aorta.   
• Examine the role of demographic characteristics and the history of cigarette smok-
ing, elevated blood pressure, and type 2 diabetes as covariates and potential effect 
modifiers of observed associations between hcPWV and abdominal aorta diame-
ters as well as between faPWV and abdominal aorta diameters.  
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i. We anticipate that strength of association between arterial stiffness and ab-
dominal aorta diameters will vary due to potential effect modifiers such as 
cigarette smoking, hypertension, and type 2 diabetes. 
• Examine the differences in the associations between central and peripheral arterial 
stiffness measured by hcPWV and faPWV, respectively, and both the anterior-
posterior (AP) and transverse abdominal aorta diameters. 
i. We hypothesize the association will be stronger using the anterior posterior 
abdominal aorta diameter. 
III.  Examine the ability of ABI and PWV to statistically predict abdominal aorta diame-
ters by deriving predictive risk equations to classify AAD at clinically meaningful 
levels.   
i. We hypothesize that lower levels of ABI will statistically predict abnormally 
dilated abdominal aorta diameters at clinically relevant cut points.    
ii. We hypothesize that higher levels of PWV will statistically predict abnormal-
ly dilated abdominal aorta diameters at clinically relevant cut points.    
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CHAPTER 3: PUBLIC HEALTH RELEVANCE AND POTENTIAL CLINICAL IMPACT  
Abdominal aortic aneurysms are common in older adults; their prevalence can reach 
12.5% in men between 75-84 years of age (Hirsch et al., 2006). AAAs are frequently asymp-
tomatic, present late, and are often diagnosed as incidental findings resulting in high levels 
of complications, morbidity and mortality. The burden of morbidity and mortality of AAAs has 
increased globally in the last decade (Lozano et al., 2012), although there are indications 
that the prevalence of AAAs may be declining in the United States. It is plausible that earlier 
diagnoses of AAAs will help to reduce their impact on morbidity and fatality. Exploring op-
tions for cost-effective, non-invasive methods to identify persons with abdominal aortic dila-
tation and AAAs is seen as an important step toward decreasing the morbidity and mortality 
from AAAs.   
The insidious progression of AAAs along with the potential for sudden rupture render 
early detection important. Consensus on the cost effectiveness of ultrasound screening for 
abdominal aortic dilatation has not been reached, and evaluation of AADs or screening for 
AAAs is not routinely performed in clinical practice. While b-mode ultrasound is the tech-
nique commonly used as the first line of investigation for abdominal aorta dilation, the meth-
od is operator-dependent, time consuming, and the equipment costs are considerable. The 
line of research submitted in this proposal is predicated on the testable expectation that 
simple, noninvasive measures of arterial atherosis and sclerosis may help identify persons 
at increased risk of having AAD or AAAs, and that these measures could facilitate targeted 
screening for AAAs in practice settings.   
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3.1. ABI and abdominal aorta diameters 
 ABI is a cost-efficient, accurate, and well-established tool to identify impaired perfu-
sion of a lower extremity, allowing for efficient diagnostic evaluation of PAD. As a marker of 
PAD, low ABI levels are indicative of increased likelihood of coronary artery disease, carotid 
artery stenosis, and cerebrovascular accident (Manzano et al., 2012; Papamichael et al., 
2000; Zheng et al., 1997). PAD also has been shown to coexist in persons with AAA 
(Axelrod et al., 2002). AADs/AAAs and peripheral arterial disease are due to atherosclerotic 
changes to the arterial wall and share pathophysiological pathways. This study will expand 
on these commonalities and examine the association between measures of lower extremity 
occlusive disease and pathologic dilatation of the abdominal aorta.  A limited number of 
studies have examined the relationship between AAA and peripheral arterial disease 
(Allardice, Allwright, Wafula, & Wyatt, 1988; MacSweeney et al., 1993).  Insights into asso-
ciations between ABI and ultrasound measures of abdominal aorta diameters will allow us to 
infer whether the well-established and simple measures of ABI have potential as indicators 
of the likelihood of abdominal aorta morphology associated with clinically defined AAA. To 
our knowledge, the ability to statistically predict AAD and AAA from ABI has not been exam-
ined. It is one of the aims of this dissertation to examine this predictive ability and to evalu-
ate the potential for a predictive algorithm of relevance to clinical practice.  
3.2. PWV and abdominal aorta diameters  
 Arterial stiffness has been proposed as a noninvasive measurement to quantify the 
risk of cardiovascular disease (Franklin, 2008). Arterial stiffening results from remodeling of 
the arterial wall resulting in diminished amounts of normal elastin coupled with increased 
amounts of abnormal collagen (Johnson et al., 2001; Zieman et al., 2005). Arterial stiffening 
occurs with aging in the abdominal aorta, to varying degrees at various segments, due to 
inherent differences in the elasticity of the anatomical aortic segments (R. T. Lee & Kamm, 
1994a). To our knowledge, the cross-sectional association between arterial stiffness and 
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AAD/AAAs has not been characterized in a community-based population of older adults. 
The purpose of this study is to examine our ability, based upon central arterial stiffness 
(hcPWV) and peripheral arterial stiffness (faPWV), to predict the diameter of the abdominal 
aorta at three pre-specified sites and to assess whether the degree of central and/or periph-
eral arterial stiffness measured by hcPWV and faPWV, respectively, are related to morpho-
logic changes in the abdominal aorta. We have chosen the aforementioned segments be-
cause they evaluate two arterial territories with different structural and physiological charac-
teristics. The hcPWV will allow us to assess the association of central arterial stiffness with 
the atherosclerotic changes that occur in the abdominal aorta. The faPWV will allow us to 
examine the association of peripheral atrial stiffness (muscular arteries) with those changes.    
 Our conclusions may speak to the potential merit of using arterial stiffness measures 
such as hcPWV and/or faPWV as convenient, reliable, and non-invasive tools to infer the 
presence of atherosclerotic changes and dilatation of the abdominal aorta.   
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CHAPTER 4: RESEARCH DESIGN AND METHODS  
4.1. Study design  
 We used data from the Atherosclerosis and Risk in Communities (ARIC) study, a 
longitudinal, multi-center, bi-ethnic, population-based cohort of 15,792 men and women 
aged 45 to 64 years of age at intake in 1987. There were five visits required: The base-line 
visit occurred between 1987 and 1989. Visits 2 through 4 occurred in 3-year intervals be-
tween 1990-1992, 1993-1995, and 1996-1998. The fifth visit occurred between 2011 and 
2013. The study was designed to examine atherosclerosis and its clinical outcomes, chang-
es in cardiovascular risk factors, and cognitive function. In addition, the ARIC study recorded 
anthropometric measurements, physical function, lung function, cardiovascular biomarkers 
and phenotypes, medical history, and other information relevant to the objectives of the 
study.  
 We used a cross-sectional design to examine the aims proposed for this dissertation. 
AADs, ABI, hcPWV, and faPWV were measured at visit 5. We used the data collected at this 
visit to characterize the distribution of AADs at specified levels of the abdominal aorta, as 
well as the pattern and strength of association of AADs with ABI, hcPWV, and faPWV. We 
took into account demographic data and potential confounders and effect modifiers. In addi-
tion, we used a cross-sectional design to build on the aforementioned analysis to examine 
the ability to statistically predict AADs from ABI, hcPWV, and/or faPWV.  
4.2. Study population 
  The analytic sample was the ARIC study. The ARIC study used a prospective epi-
demiologic cohort and was conducted in four locations in the U.S.; Washington County, 
Maryland; Minneapolis, Minnesota; Jackson, Mississippi; and Forsyth County, North Caroli-
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na. The four locations included rural, suburban, and urban settings ("The Atherosclerosis 
Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators," 1989). 
The ARIC study was designed to examine the etiology, natural history, and clinical manifes-
tations of atherosclerosis, taking into account cardiovascular risk factors, race, gender, loca-
tion, and date. The study started in 1987 and was sponsored by the NHLBI. Around 4,000 
participants between 45 and 64 years of age were randomly selected from each of the four 
communities listed above. Age-eligible persons were randomly sampled from listings in 
Washington County, Minneapolis, and Jackson, Mississippi, using driver’s licenses, private 
county health censuses, persons eligible for jury duty, and persons with state identification 
cards ("The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The 
ARIC investigators," 1989). However, in Forsyth county persons were identified by area 
sampling ("The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. 
The ARIC investigators," 1989).  
 The first visit was from 1987 to 1989. Medical, social, and demographic data were 
obtained from 15,792 persons. Three re-examination visits were conducted every three 
years, with 93%, 86%, and 80% response rates for the second, third, and fourth visits, re-
spectively. The fifth visit was conducted between June 2011 and August 2013. The re-
sponse rate for visit 5 was 65%, which represents the 6,538 participants that took part in vis-
it 5 divided by the 10,036 cohort members alive through August 2013.  
4.3. AAD: Measurements and data quality 
Abdominal aorta diameters were measured by high resolution, real-time duplex ultra-
sound (Philips IE33). To ensure data quality, involved personnel, radiologists, and certified 
technologists were recruited and trained to follow standardized ARIC protocols. 
Transverse images at five different segments of the abdominal aorta were taken to 
identify the antero-posterior and transverse diameters. The transverse images were taken at 
the following anatomical positions: proximal aorta below the superior mesenteric artery, 
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proximal infrarenal aorta 2 cm below the renal arteries, distal infrarenal aorta 1 cm superior 
to the aortic bifurcation, and the point of maximal abdominal aortic dilatation if it was not at 
the level of the proximal or distal infrarenal aortas. Additional transverse images were taken 
in the case of a possible AAA (maximum diameter ≥ 2.8 cm). In addition, a longitudinal view 
was taken of the infrarenal abdominal aorta from the renal arteries to the bifurcation of the 
abdominal aorta. Participants with a history of previous AAA repair or previous aortic bypass 
surgery for occlusive atherosclerotic disease were not scanned. All abnormal abdominal 
aortic scans and a 5% random sample of normal scans were sent to ARIC’s aortic imaging 
core laboratory for diagnosis of AAAs and other possible pathologies (Table 1). To support 
the quality of the scans, 10 randomly selected studies were evaluated for each technologist, 
and recommendations for improvement were distributed to all technologists. Based on 900 
quality control abdominal aorta scans (Table 2), 32% were excellent, 29% were good, 15% 
were fair, and 23% were poor. 
Table 1. Completion Status of Quality Control Measures Based on ARIC Data Retrieved Oc-
tober 23, 2013 
Procedure 
 
Time 
interval 
(months) 
Total tests 
received from 
reading cen-
ter 
Number of 
QC re-
quired 
 
Total QC 
records 
entered 
Total QC in 
the previous 
time interval 
% QC com-
pleted from 
selection for 
the previous 
time interval 
Abdominal 
aorta scan 
1 5913 All the ab-
normal plus 
5% of the 
normal 
scan 
900 1 NA 
PWV/ABI 1 5672 40/month 487 37 97 
Table 2. Abdominal Aorta Scan Quality Control Measures Based on ARIC Data Retrieved 
October 23, 2013 
Procedures Excellent Good Fair Poor NA Total 
N % N % N % N % N %  
Abdominal aorta 
scan 
284 32 265 29 131 15 209 23 11 1 900 
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4.4. Arterial stiffness and PAD: Measurements and data quality 
Femoral-ankle pulse wave velocity and ABI were used to evaluate peripheral arterial 
stiffness and PAD, respectively, and heart-carotid pulse wave velocity was used to evaluate 
central arterial stiffness. ABI, hcPWV, and faPWV were measured concurrently at ARIC visit 
5 using an automated non-invasive waveform analyzer, the VP-1000 Plus device (Omron 
Co., Ltd., Kyoto, Japan). This analyzer had been selected on the basis of prior validation 
studies and because it would reduce observer-dependent variability as well as exam time. 
Trained and certified technicians performed the measurement process by following a stand-
ardized protocol. Four size-appropriate blood pressure cuffs were attached to both arms and 
ankles to record the systolic blood pressure and pressure pulse waves, respectively. A ca-
rotid sensor, a femoral sensor, and two ECG sensors were applied. Two measurements 
were taken to reduce process variability; the second measurement was obtained two to five 
minutes after the first measure.  A third measurement was performed if the study technician 
experienced difficulties in obtaining an optimal pulse wave form on the display, in which 
case technologists waited 2-5 minutes to obtain a third measurement. The average of the 
last 2 non-zero measurements were used. 
Table 3. PWV/ABI Quality Control Quality Measures Based on ARIC Data Retrieved     
October 23, 2013 
Procedure 
Quality  
Optimal Good Acceptable Poor Unacceptable NA Total 
N % N % N % N % N % N %  
PWV/ABI 380 78 85 17 16 3 0 0 0 0 6 1 487 
The right and left ABI values are the average of the ankle systolic blood pressure of 
the respective limb, divided by the corresponding average brachial systolic blood pressure. 
The higher-average brachial systolic pressure was used if there was a difference of 10 mm 
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Hg or more between the right and left averages and either the left or right pressure was 
higher for both measurements.  
Currently, no clinical threshold levels for hcPWV and faPWV have been identified. 
Because of this, heart- carotid PWV and faPWV were recorded for research purposes, but 
the results were not reported to participants. A summary report of the ABI values was deliv-
ered to participants and their health care providers about 6 weeks after the ARIC exam visit.  
According to the AHA standards, ABI values between 1.00-1.30 are considered normal, the 
range 0.91-0.99 is considered borderline, 0.41-0.90 is indicative of mild to moderate dimin-
ished arterial supply, equal or less than 0.40 is indicative of severely diminished arterial 
supply, and more than 1.40 is attributed to incompressibility of the arteries and arterial calci-
fication (Hirsch et al., 2006; Rooke et al., 2011). 
Table 4. ICCs and 95% CIs for faPWV, hcPWV, and ABI 
Index ICC (95% CI) SEM MDC95 
Right faPWV * 0.69 (0.59, 0.79) 108.7 301.4 
Left faPWV * 0.57 (0.43, 0.71) 117.3 325.1 
hcPWV * 0.44 (0.26, 0.61) 215.0 596 
Right ABI § 0.48 (0.34, 0.64) 0.08 0.22 
Left ABI § 0.61 (0.48, 0.73) 0.07 0.20 
ICC: Intra-class Correlation Coefficient; SEM: Standard Error of Measurement;  
MDC95: Minimal Detectable Change 
* First author: Snyder (Snyder et al., 2015) 
§ First author: Al-Qunaibet (Al-Qunaibet et al., 2015) 
Data quality assurance was maintained by following standardized protocols and pro-
cedures, recruiting qualified personnel, training certified ARIC technicians, quarterly equip-
ment maintenance and calibration, providing feedback and troubleshooting, and quality con-
trol reviews. Throughout the study, random samples of records for PWV/ABI were reviewed 
for all centers; forty records per month were reviewed, reaching a total of 487 records (Table 
3). Quality scores were calculated based on the 487 records reviewed per year, and 78% of 
40 
the records were considered of optimal quality, 17% were of good quality, 3% were ac-
ceptable, and none were graded as poor or of no quality (Table. 3). The repeatability of 
hcPWV, faPWV, and ABI was characterized in a subset of ARIC participants (N = 79) (Al-
Qunaibet et al., 2015; Snyder et al., 2015). The participants in the subset underwent two ex-
aminations 4-8 weeks apart using the standardized protocols applied in the full cohort to 
measure ABI and PWV. The intra-class correlation (ICC), corresponding 95% confidence 
intervals (95% CI), minimal detectable change (MDC95), and standard error of measurement 
were calculated indicating acceptable-to-substantial repeatability measures for ABI, faPWV, 
and hcPWV (Table 4).  
Based on the PWV repeatability study performed on ARIC visit 5 data, we consid-
ered the repeatability of faPWV and hcPWC acceptable (Snyder et al., 2015). The ICCs and 
95% CIs indicate substantial repeatability for right faPWV ICC 0.69 (0.59, 0.79), moderate 
repeatability for left faPWV ICC 0.57 (0.43, 0.71), and moderate repeatability for hcPWV ICC 
0.44 (0.26, 0.61), according to the categorization of Landis et al. (Landis & Koch, 1977). To 
our knowledge, the repeatability and accuracy of faPWV using the Omron VP-1000 plus de-
vice used in the ARIC study at visit 5 has not been thoroughly examined. However, similar 
automated devices have demonstrated high repeatability and accuracy (Asmar et al., 1995; 
Cooper, Tepper, Barinas-Mitchell, Woodard, & Sutton-Tyrrell, 2012; Tanaka et al., 2006; 
Yamashina et al., 2002).  
The faPWV ICC within technicians and between technicians using an automated 
noninvasive Omron VP-2000 has been reported to be 0.96 and 0.87, respectively (Cooper 
et al., 2012), indicating almost perfect agreement according to categorization proposed by 
Landis et al. The coefficient of variation for faPWV has been reported to be 3.3% in 17 
healthy individuals based upon measurements using an automatic waveform analyzer 
(Tanaka et al., 2006), and this is almost identical to the coefficient of variation for the femo-
ral artery intima-media thickness measured ultrasonographically (Kumeda et al., 2002).  
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However, we were not able to find contrasts made between left and right faPWV repeatabil-
ity in the literature to compare to the left and right faPWV repeatability conducted in the 
ARIC study.  
The AHA recognizes the ABI as a source of objective data that provides level B evi-
dence in many clinical scenarios (Hirsch et al., 2006) and is a non-invasive measure with 
well-established accuracy (Feigelson, Criqui, Fronek, Langer, & Molgaard, 1994; Nassoura 
et al., 1996).  The ICCs were calculated in ARIC visit 5 as a statistic for reliability; they indi-
cate fair reliability for right ABI (ICC = 0.48, 95%CI 0.34, 0.64) and left ABI (ICC = 0.61, 95% 
CI 0.48, 0.73), according to the Landis et al. categorization (Landis & Koch, 1977). Prior to 
ARIC visit 5, ABI had been measured using DINAMAPTM, another automated oscillometric 
device ("The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The 
ARIC investigators," 1989), and the reliability coefficient was 0.61 (95% CI 0.51, 0.70) 
(Weatherley, Chambless, Heiss, Catellier, & Ellison, 2006). The validity and reliability of au-
tomated oscillometric ABI have been measured against manually measured ABI using Dop-
pler, the gold standard for ankle blood pressure measurement in calculating ABI (Hirsch et 
al., 2006), and there is an overall agreement on the high reliability and acceptable validity of 
automated oscillometric ABI measurement (Kollias, Xilomenos, Protogerou, Dimakakos, & 
Stergiou, 2011; Richart, Kuznetsova, Wizner, Struijker-Boudier, & Staessen, 2009; Verberk, 
Kollias, & Stergiou, 2012).  
4.5. Statistical analyses overview 
As mentioned above, the population for this study was the ARIC cohort at visit 5, and 
we used a cross-sectional design to pursue the three aims stated for this dissertation. The 
primary outcome was abdominal aorta diameter at three standardized locations (in centime-
ters), measured ultrasonographically. We analyzed AADs on a continuous scale and a cate-
gorical scale. Abdominal aortic aneurysm was considered to be present when the anterior 
posterior diameter of the abdominal aorta was 3 cm or more (Hirsch et al., 2006). Therefore, 
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we dichotomized AADs according to the 3 cm threshold and also created distribution-based 
categories for AADs at proximal, mid-, and distal locations. 
 There were two traits of main interest for this analysis: central and peripheral arterial 
stiffness measured by hcPWV and faPWV respectively, and peripheral arterial disease 
measured by ABI. Established clinical cut points do not exist for hcPWV and faPWV; there-
fore, arterial stiffness was analyzed on a continuous scale. Peripheral arterial disease is 
suggested by an ABI of < 0.90, and a normal ABI range is 1.00 to 1.40(Hirsch et al., 2006). 
We similarly analyzed ABI on a categorical and continuous scale. We included covariates 
that are established or suspected risk factors for dilated AADs and that could potentially 
confound the peripheral arterial disease by AAD relationship, central arterial stiffness by 
AAD relationship, and peripheral arterial stiffness by AAD relationship. These factors includ-
ed age, gender, and race.  Cigarette smoking, systolic blood pressure, blood pressure med-
ication, and diabetes were introduced as covariates in sensitivity analyses.   
 Aim I: Describe the distribution of abdominal aorta diameters at proximal, mid-, and 
distal locations by levels of peripheral artery disease measured by ABI at the ARIC cohort 
Visit 5 examination. 
 Aim I analyses were performed with three goals: a) to examine the distribution of ABI 
in the ARIC cohort visit 5, b) to examine the distribution of AADs at proximal, mid-, and distal 
locations, c) to characterize the strength and shape of association between ABI and AADs 
at proximal, mid-, and distal locations, and across the range of ABI values. The outcome of 
interest for Aim I is AAD at the proximal, mid-, and distal locations. The exposure of interest 
for Aim I is PAD as measured by ABI. The outcome and exposure were both analyzed on 
continuous and categorical scales, as stated above.  
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4.5.1 Distribution of PAD 
We performed univariate analyses of ABI on a continuous scale and calculated the 
mean, median, and standard deviation, assessing the shape of the distributions. In addition, 
we used the four ABI categories described previously in section B.2.1. that consist of ≤ 0.40, 
0.41-0.90, 0.91-0.99, 1.00-1.29, and > 1.30 (Hirsch et al., 2006; Rooke et al., 2011). To ana-
lyze ABI on a categorical scale, we tabulated frequencies for the four ABI categories. Fol-
lowing the analyses of ABI in the ARIC cohort at visit 5, we examined the anticipated heter-
ogeneity in ABI values, stratifying by gender and race.  
4.5.2 Distribution of AADs 
We examined the distribution of AADs as a continuous, dichotomous, and categori-
cal variable. Initially, we explored the distribution of AADs as a continuous variable and as-
sessed any impact of missing data or extreme values. The mean, standard deviation, and 
the shape of the distribution were calculated. We proceeded by superimposing cut points, 
thus creating distribution-based categories. We also used a cut point of 3 cm anterior-
posterior diameter to create a dichotomous variable. Appropriate descriptive statistics were 
used for categorical and dichotomous AADs. The aforementioned statistical analysis steps 
were repeated for AADs at proximal, mid-, and distal locations. Therefore, in this section of 
analyses we were able to compare the variation in the descriptive statistics for AADs at 
three deferent anatomical levels.    
4.5.3 Strength of association between PAD and AADs 
We examined the strength and shape of association between the exposure of inter-
est (ABI) and the outcome of interest (AADs) at proximal, mid-, and distal locations. To thor-
oughly examine the association, we repeated the statistical analyses to include the expo-
sure and outcome as both continuous and categorical variables. This mandated creating a 
set of bivariable analyses that included continuous exposure and outcome, continuous ex-
posure and categorical outcome, continuous exposure and dichotomous outcome, categori-
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cal exposure and outcome, categorical exposure and continuous outcome, and categorical 
exposure and dichotomous outcome. Each variation of outcome and exposure analyses was 
repeated for AADs at the above-mentioned anatomical locations.  We used Pearson’s Chi-
Square and the test for trend to perform bivariable comparisons between ABI and AADs, 
both as categorical variables. We used one-way analysis of variance to examine the 
strength and shape of association between ABI on a categorical scale and AADs on a con-
tinuous scale. To assess the association between ABI and AADs as continuous variables, 
we used Pearson’s correlation and quintile regression.  
4.5.4 Assess covariates as confounders and effect modifiers for the associations be-
tween ABI and AADs  
Covariates of interest include age, gender, cigarette smoking, elevated blood pres-
sure, and type 2 diabetes. We performed descriptive analyses for continuous and categori-
cal covariates, assessing the covariates as confounders or possible modifiers of the associ-
ation between ABI and AADs.  
Aging, cigarette smoking, elevated blood pressure, and diabetes are the most im-
portant covariates according to the literature to better characterize the concurrent associa-
tion between ABI and AAD. Therefore, we considered it to be a priority to exercise analytic 
control of the concurrent/contemporaneous effect of cigarette smoking, elevated blood pres-
sure, and diabetes in the estimation of cross-sectional associations with measurements of 
AAD. To do so, we adjusted for the above-mentioned covariates and characterized the de-
gree and strength of the association and the change in estimates compared to the crude es-
timates. Thereafter, we performed stratification to examine and compare the degree and 
level of association to that calculated from adjustment models. We acknowledge that resid-
ual confounding between long-term exposures and chronic conditions cannot be removed in 
a cross-sectional analysis among older adults.  
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Based on the conclusions reached from the above analyses, we proceeded to per-
form multivariable analyses. The exposure of interest and outcome of interest were ana-
lyzed on continuous and categorical scales. We used analysis of covariance and percentile 
regression to estimate the mean difference in AAD on a continuous scale between normal 
and abnormal ABI levels, adjusted for covariates. We also estimated the mean difference in 
AAD for a unit change in ABI when analyzed on a continuous scale adjusted for covariates. 
We fit a multinomial regression model analyzing AAD on a nominal scale. We estimated the 
odds of dilated abdominal aorta diameters for each of the normal and abnormal ABI levels, 
adjusting for covariates. We also estimated the odds of dilated abdominal aorta diameters 
for selected ABI values. Throughout the process of multivariable analyses, we took into ac-
count the possibility of effect modifiers and dealt with them accordingly. 
Aim II: Describe the distribution and association of central and peripheral arterial stiffness 
measured by hcPWV and faPWV, respectively, and anterior-posterior abdominal aorta di-
ameters at proximal, mid-, and distal locations at the cohort Visit 5 examination. 
 Aim II analyses were performed with three goals: a) to examine the distribution of 
central PWV and peripheral PWV in the ARIC cohort at visit 5, b) to characterize the 
strength and shape of the association between central arterial stiffness measured by 
hcPWV and AADs at proximal, mid-, distal locations, and c) to characterize the strength and 
shape of association between peripheral arterial stiffness measured by faPWV and AADs at 
proximal, mid-, distal locations. The outcome of interest for aim II was AADs at proximal, 
mid-, and distal locations. The outcome was analyzed on continuous, dichotomous, and cat-
egorical scales, as previously explained in Aim I. Central and peripheral arterial stiffness 
were the exposure variables. They were measured by hcPWV and faPWV, respectively, and 
were analyzed as continuous variables. Each exposure variable was analyzed independent-
ly.  
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4.5.5 Distribution of central and peripheral arterial stiffness 
This part of Aim II involves descriptive analyses of hcPWV and faPWV on a continu-
ous scale. We performed univariate analyses calculating the mean, median, standard devia-
tion, and interquartile ranges, assessing the shape of the distributions. We anticipated that 
the distribution of arterial stiffness would differ by age, race, and gender. To address this, 
we compared the mean for hcPWV and faPWV in the different categories of race and gen-
der. Gender and race are dichotomous independent variables. A 2-sample t-test was per-
formed to compare changes in PWV values for gender and race categories.     
4.5.6 Strength of association between arterial stiffness and AADs 
We examined the strength and shape of the association between the exposures of 
interest (central and peripheral arterial stiffness) and the outcome of interest (AADs at prox-
imal, mid, and distal locations). The strength of the association between the two exposures 
of interest and outcome was examined separately. The exposures were analyzed only on a 
continuous scale and the outcome on continuous, dichotomous, and categorical scales.  
Therefore, we created a set of bivariable analyses that included: continuous exposure and 
outcome, continuous exposure and categorical outcome, and continuous exposure and di-
chotomous outcome. Each variation for outcome and exposure analyses was repeated for 
each exposure (hcPWV and faPWV) and for anterior-posterior AADs at the above-
mentioned anatomical locations. We used Pearson’s correlation and quantile regression to 
examine the strength and shape of the association between hcPWV and AADs and between 
faPWV and AADs on a continuous scale. We used logistic regression to assess the strength 
and direction of the association between the exposures of interest on a continuous scale 
and AADs on a categorical scale.  
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4.5.7 The role of identified covariates on the associations between PWV (central and 
peripheral) and AADs  
Covariates of interest include age, gender, cigarette smoking, elevated blood pres-
sure, and type 2 diabetes. Aging, cigarette smoking, and type 2 diabetes are shareholders in 
the pathophysiological process of developing arterial stiffness and abdominal aortic dilata-
tion. Elevated blood pressure is a strong hemodynamic determinant of PWV and AAD. It 
was important to examine how these covariates affected the strength and degree of the as-
sociation between PWV (exposure) and AAD (outcome). As explained in Aim I, we em-
ployed stratification and adjustment. We assessed the change in the degree and level of as-
sociation between PWV and AAD, how the estimates of AAD changed, and how useful the 
estimates were depending on the method used.  
We performed descriptive analyses for continuous and categorical covariates and 
assessed the covariates as confounders or possible modifiers of the association between 
PWV (central and peripheral) and AADs. Based on the conclusions reached from the above 
analyses, we proceeded to perform multivariable analyses to assess separately the associa-
tion between central arterial stiffness and AADs and between peripheral arterial stiffness 
and AADs. Central and peripheral arterial stiffness were analyzed on a continuous scale, 
and AADs were analyzed on a continuous scale and distribution-based categories. We used 
analysis of covariance and percentile regression to estimate the mean difference in AADs 
on a continuous scale for a unit change in PWV adjusted for covariates. We fit a multinomial 
regression model analyzing AAD on a categorical scale and PWV on a continuous scale. 
We estimated the odds ratio for dilated abdominal aorta diameters for selected central and 
peripheral pulse wave velocity values. Throughout the process of multivariable analyses, we 
took into account the possibility of effect modifiers and deal with them accordingly. 
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Aim III: Examine the ability to statistically predict abdominal aorta diameters from ABI and 
PWV by deriving predictive portability equations to classify AAD at clinically meaningful lev-
els.   
 Aim III analyses was planned to build on the knowledge gained from the analyses 
proposed for Aims I and II. The purpose of Aim III was to create and test predictive models 
to estimate the probability of abdominal aortic diameters based upon ABI and PWV levels 
and suspected risk factors. We were planning to develop a parametric bi-normal model that 
includes the best predictors (variables) of abdominal aortic diameters. In a base model, we 
would have considered age, gender, race, cigarette smoking, elevated blood pressure, and 
diabetes in the model prediction of AAD. We would have considered the aforementioned 
factors since they are involved in the pathophysiology of the process, but we would have 
also considered other variables such as body surface area and lipid levels that improve the 
statistical prediction. Once we have assessed the goodness-of-fit using the Hosmer-
Lemeshow decile of probability test (161, 162), we would have optimized the most parsimo-
nious predictive model using multiple degrees of freedom likelihood ratio tests for groups of 
variables and by using a stepwise method. We would have then quantified the classification 
properties of the model using the c statistic (increment in the area under the receiver-
operator curve [ROC]) to establish the accuracy, sensitivity, and specificity of the base mod-
el to predict AADs (Zou, O'Malley, & Mauri, 2007).  
ABI, hcPWV, and faPWV would have then be added to the baseline parametric bi-
normal model to assess improvements in its predictive ability, as quantified by the AUC and 
the net reclassification index (NRI). The latter would have been used to assess the model’s 
predictive ability to assign a higher probability to individuals with abdominal aortic diameter 
dilatation. NRI is commonly estimated as NRI = (probability of cases moving upward – prob-
ability of cases moving downward) – (probability of non-cases moving upward – probability 
of non-cases moving downward) (Pencina, D'Agostino, D'Agostino, & Vasan, 2008). NRI 
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would have estimated the percent of individuals reclassified from one category to another 
when ABI and/or PWV are added as compared to a predictive model without ABI and/or 
PWV. We had planned to examine the correct movement of individuals from one AAD prob-
ability category to another. (The movement from a lower probability of dilated AAD to a 
higher probability of dilated AAD is considered an upward movement) (Pencina et al., 2008).  
Finally, we would have attempted to correct for optimism and internally “validate” the 
model. Although an external validation is more desirable, at this point we do not know of any 
other study population that has been characterized comparably and can serve as a replica-
tion set. Bootstrapping, split tests and cross-validation are known as “validation” methods 
(Steyerberg et al., 2001). For this study we would have performed bootstrapping because 
the study size is not large enough for split validation and because bootstrapping provides 
stable estimates and lower bias than split tests and cross-validation (Steyerberg et al., 
2001). The number of iterations that would have been used to arrive at stable estimates 
would have been determined during study anlaysis. All analyses will be performed using 
Stata 13 (College Station, TX). 
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CHAPTER 5: MANUSCRIPT 1- PERIPHERAL ARTERIAL DISEASE AS AN INDICATOR 
OF ENLARGED ABDOMINAL AORTA DIAMETERS. THE ATHEROSCLEROSIS RISK IN 
COMMUNITIES (ARIC) STUDY. 
5.1 Introduction 
 Ankle brachial index (ABI) is a non-invasive tool used to assess peripheral arterial 
occlusive disease. Large cohort studies have reported an association of lower levels of ABI 
and central atherosclerotic changes, including subclinical atherosclerosis, clinical coronary 
artery disease, incident ischemic strokes, and recurrent strokes (Feringa et al., 2007; A. J. 
Lee et al., 2004; McDermott et al., 2005; Otah et al., 2004; Papamichael et al., 2000; 
Resnick et al., 2004; Tsai et al., 2001; Zheng et al., 1997). Furthermore, ABI has been 
shown to aid in identifying persons with moderate to high cardiovascular risk and is a predic-
tor of cardiovascular morbidity and mortality (A. J. Lee et al., 2004; Papamichael et al., 
2000; Resnick et al., 2004). While ABI has been associated with atherosclerotic occlusive 
disease in the coronary, carotid, and peripheral arteries, the abdominal aorta is also a site of 
predilection and of early onset of atherosclerosis that may lead to abdominal aortic dilatation 
and loss of the tapered, cylindrical shape of this segment of the aorta. Abdominal aortic an-
eurysms (AAAs) are conventionally defined as an anterior-posterior diameter of the ab-
dominal aorta of 3 cm or more (Hirsch et al., 2006). The pathophysiology of AAA is complex 
and involves atherosclerotic changes and remodeling of the arterial wall by increased pro-
duction of collagen and degradation of smooth cells, which results in arterial stiffening 
(Ailawadi, Eliason, & Upchurch, 2003; Allison, Hiatt, Hirsch, Coll, & Criqui, 2008; Nordon, 
Hinchliffe, Loftus, & Thompson, 2011; Raaz et al., 2014; P. K. Shah, 1997). Low ABI values, 
which indicate a higher likelihood of coronary artery disease, carotid artery stenosis, and/or 
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peripheral artery disease (PAD), have been shown to coexist in persons with abdominal aor-
tic aneurysms (Axelrod et al., 2002). 
 The ABI is an established marker of peripheral, atherosclerotic occlusive arterial dis-
ease. Its use in general clinical practice has been recommended by a consensus of profes-
sional associations (Hirsch et al., 2006). The American Heart Association (AHA) recom-
mends measuring the ABI in individuals who are 70 years or older, suffering from leg symp-
toms on exertion, or with chronic wounds, for whom PAD is the suspected diagnosis (level of 
evidence: C) (Hirsch et al., 2006). The AHA also recommends measuring the ABI in diabet-
ics or individuals with a history of smoking who are 50 years of age or older (level of evi-
dence: C) (Hirsch et al., 2006). In contrast, imaging procedures to assess the morphologic 
characteristics and diameters of the abdominal aorta that may be indicative of underlying 
atherosclerosis are recommended only for high risk groups (Hirsch et al., 2006; "Summaries 
for patients. Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force 
recommendation statement," 2014). Measurement of the ABI with a Doppler probe or one of 
the several validated oscillometric devices that are available is inexpensive and easy to per-
form in a practice setting, in contrast to the measurement of abdominal aorta diameter 
(AAD) by one of several imaging techniques available. Therefore, the ability to glean infor-
mation about abdominal aortic dilatation or AAA from an ABI measurement presents itself as 
a potentially cost effective and clinically attractive option.  
  There is limited information available on the association between PAD and AAD, 
most of it based on small populations of individuals selected on the basis of PAD manifesta-
tions (Allardice et al., 1988; MacSweeney et al., 1993). Reports indicate a high prevalence 
of AAA (6.4%-20%) in such individuals. These findings may not be generalizable beyond 
study populations enriched for atherosclerosis and thus at high risk for atherosclerotic mani-
festation elsewhere. Whether ABI is associated with abdominal aorta dilatation or AAA in the 
general population has not been reported, to our knowledge. 
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 Insights into the strength of the association between ABI and abdominal aortic ultra-
sound measures will allow us to assess whether information about abdominal aortic diame-
ter can be inferred from ABI levels in a population-based study. Accordingly, this study ex-
amined the association between ABI and the anterior-posterior diameters of the abdominal 
aorta at pre-specified anatomical sites in a population-based, biracial cohort of men and 
women ages 70-89 years.   
5.2 Methods 
5.2.1 Study population  
 We conducted a cross-sectional analysis of data from the 5th examination of the Ath-
erosclerosis Risk in Communities (ARIC) study cohort (2011-2013) sponsored by the Na-
tional Heart, Lung, and Blood Institute (NHLBI). The ARIC study is a prospective epidemio-
logic study of adults aged 45 and 64 years at intake in 1987-89, drawn as probability sam-
ples from four U.S. communities (Washington County, Maryland; suburban Minneapolis, 
Minnesota; Jackson, Mississippi; and Forsyth County, North Carolina) ("The Atherosclerosis 
Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators," 1989). 
The response rate for visit 5 was 65%, which represents 6,538 participants. Of those, 5,683 
completed the measurements needed for this study.  
We excluded from these analyses 881 examinees due to characteristics that pre-
cluded the measurement of ABI or AAD or that affected data quality. We excluded partici-
pants with missing AAD values, a body mass index (BMI) ≥ 40kg/m2, aortic stenosis, mod-
erate or greater aortic regurgitation, aortic revascularization, peripheral revascularization, 
evidence of a major arrhythmia (Minnesota code 8-3-1) on a 12-lead electrocardiogram, and 
missing ABI values. Only whites and African-American participants were included and racial 
groups that were represented in numbers insufficient for analysis were excluded. The study 
was approved by the Institutional Review Board at each participating institution. Written in-
formed consent was provided to the participants for each examination.  
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All measurements were obtained by trained technicians following standardized pro-
tocols. Participants were asked to fast for 8 hours prior to their clinic visit and to avoid tobac-
co use and vigorous physical activity.  They were also requested to bring all medications 
(prescription and non-prescription) with them. Participants provided medical history and life-
style information by completing interviewer administered questionnaires.  Blood and urine 
specimens were obtained and shipped for assay and long term storage at three core labora-
tories. Anthropometric measurements, a standard 12-lead electrocardiogram, standing 
height measurement, body weight measurement and three seated blood pressure meas-
urements were obtained using an oscillometric automated sphygmomanometer (Omron Co., 
Ltd., Kyoto, Japan). Hypertension was defined as systolic blood pressure (mean of 2nd and 
3rd measures) ≥ 140 mmHg or diastolic blood pressure (mean of 2nd and 3rd measures) ≥ 
90 mmHg, or on medication for high blood pressure. Diabetes was defined as present if glu-
cose value ≥ 126 mg/dL or non-fasting glucose value ≥ 200 mg/dL, or using medication for 
diabetes or a self-report of physician-diagnosed diabetes. Details are available in Manual 2 
(Home and Field Center Procedures) at (https://www2.cscc.unc.edu/aric/cohort-manuals).  
Abdominal aorta diameters  
Abdominal aorta diameters were measured by high resolution, real-time duplex ultra-
sound (Philips IE33). The participants were asked to fast for at least 8 hours prior to their 5th 
ARIC clinic visit as described above. To ensure data quality, the radiologists and certified 
technologists were trained to follow standardized ARIC protocols. Transverse and anterior-
posterior diameters were measured at three standardized levels of the abdominal aorta. The 
images were taken at the following anatomical positions: proximal aorta below the superior 
mesenteric artery, mid aorta 2 cm below the renal arteries, distal infrarenal aorta 1 cm supe-
rior to the aortic bifurcation, and the point of maximal abdominal aortic dilatation if it was not 
at the level of the proximal or distal infrarenal aorta. Additional transverse images were tak-
en in the case of a possible AAA (maximum diameter ≥ 2.8 cm). Participants with a history 
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of previous AAA repair or previous aortic bypass surgery for occlusive atherosclerotic dis-
ease were not scanned. In this study we will focus on proximal anterior-posterior abdominal 
aorta diameters.  
Ankle-brachial index 
 ABI was measured using the automated waveform analyzer VP-1000 Plus (Omron 
Co., Ltd., Kyoto, Japan) (Cortez-Cooper, Supak, & Tanaka, 2003) following a standardized 
protocol. This device employs a double cuff technology where one cuff inflates while the 
other detects oscillation. The participant was in the supine position with both arms resting 
along his/her side (Meyer et al., 2016). Two electrocardiogram clips were attached on the 
inner sides of both wrists, and size-appropriate blood pressure cuffs were placed on both 
arms and ankles. Blood pressure was measured simultaneously in the four limbs at least 
twice at an approximately 5-minute interval. The VP-1000 Plus estimates ABI for each lower 
extremity as ABI = ankle systolic blood pressure / (higher of left and right arm systolic blood 
pressure) and the lower ABI value for each individual was used in the analysis.  
Statistical analysis  
 We examined the distribution, means, and standard deviations of ABI and AAD in the 
ARIC cohort at visit 5. We then characterized the strength and shape of the association be-
tween ABI and AAD across the range of ABI values. In examining the association, we se-
lected the continuous forms of ABI and AAD to be included in the final statistical model, as 
they best captured the association. The final linear regression model included AAD as the 
outcome and ABI as the exposure, with the first- and second-order terms of ABI adjusted for 
age.  
The mean, standard deviation, and the shape of the distribution were examined for 
each continuous variable, and frequencies were tabulated for categorical variables. We con-
sidered the following as potential covariates and effect modifiers of the association between 
ABI and AAD:  age, gender, race, cigarette smoking, elevated blood pressure, and diabetes 
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mellitus. To achieve our study goal to assess the ability to predict AAD from ABI only, the 
only covariate adjusted for was age, since it is not our purpose to account for or partially ex-
plain the mechanisms behind an association of ABI and AAD. We also assessed the ability 
of ABI to predict AAD in the presence of other characteristics (gender, race, elevated blood 
pressure, diabetes, and smoking) that can plausibly aid in the prediction of AAD. The analyt-
ic steps were repeated to examine the association between ABI with mid-anterior-posterior 
AAD and distal anterior-posterior AAD. All statistical tests are 2-sided, with a nominal signifi-
cance level of P < 0.05. All analyses were performed using Stata, version 14.0 (StataCorp 
LP, College Station, TX).  
5.3 Results 
In our study population, 4,802 of ARIC visit 5 participants met our criteria for inclu-
sion in the analysis. As shown in Table 5, 1,059 (22.0%) were African-American, 2,841 
(59.1%) were women, 2,565 (57.2%) were current or prior smokers, 1,440 (30.3%) were di-
abetics, and 3,450 (72.5%) were hypertensives. The mean age and BMI were 75.3 ± 5.1 
years and 27.9 ± 4.5 kg/m2, respectively.  
The overall mean and standard deviation for proximal, mid-, and distal anterior-
posterior AAD were 1.95 ± 0.32 cm, 1.81 ± 0.33 cm, and 1.70 ± 0.35 cm, respectively (Table 
5).  The variation in AAD by race and gender is shown in Figure 3. The median values for 
anterior-posterior AAD at proximal, mid-, and distal locations were 1.9 cm, 1.8 cm, and 1.7 
cm, respectively (Table 6), and less than 1% (N = 39) of participants had an AAD larger than 
2.9 cm (Table 6). The overall mean for ABI was 1.10 ± 0.14 (Table 5), the ABI was approxi-
mately normally distributed with a median value of 1.13; approximately 7% of the partici-
pants had an ABI value below 0.9 (N = 343).  The variation in ABI by race and gender is 
shown in Figure 4. 
There was statistically significant (P ≤ 0.05) effect measure modification of the asso-
ciation between ABI and AAD by race and smoking status. The difference in the magnitude 
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of the association between strata in the presence or absence of the effect-modifying variable 
was less than 4 mm in anterior-posterior proximal AAD. We considered the small magnitude 
of this modification to be ignorable and did not include these covariates in the estimation of 
the results presented here.  
The estimates of association (95% confidence intervals) between the ABI and proxi-
mal anteroposterior AAD adjusting for age were, -1.26 (-1.77, -0.74) for ABI and 0.74 (0.49, 
0.99) for squared. Significant P values (< 0.0001) for both ABI and ABI squared indicate 
non-linear associations between ABI and AAD. The fitted scatter plot for the association be-
tween ABI and AAD approximates a shallow concave shape showing a gradual increase in 
the AAD at the lower (< 0.5) and higher (> 1.4) ABI values (Figure 5). The estimated mean 
and (95% confidence intervals) for proximal anteroposterior AAD in a 75 year old participant 
(median age for study cohort) at ABI values of 0.5, 1.1, and 1.4 is 1.98 cm (1.91, 2.05), 1.94 
cm (1.93, 1.95), and 2.11 cm (2.08, 2.15), respectively. We examined how the association 
between ABI and the proximal anteroposterior AAD would change by adding gender to the 
model. The association was no longer statistically significant once gender was added, and 
the estimates and (95% confidence interval) for ABI and ABI squared were 0.1 (-0.4-0.6) and 
-0.01 (-0.3-0.2). The adjusted R-squared was ~0.017 for the model that only adjusted for 
age and for the model that adjusted for both age and gender. 
In a fully adjusted model (Table 7), the estimates of association between ABI and 
AAD were visibly attenuated. The pattern of association between ABI and both mid and dis-
tal anteroposterior AADs was the same but weaker than that seen between ABI and proxi-
mal anteroposterior abdominal aorta diameter (results not shown).  
5.4 Discussion  
 In a population-based, cross-sectional examination of older men and women, ABI is 
associated with the anterior-posterior diameters of the abdominal aorta. Abdominal aorta 
diameters are greater at low as well as at high ABI values. It is worth noting that the U-
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shaped association is consistent with atherosclerotic pathophysiological changes underlying 
higher and lower ABI measurements (Allison et al., 2008; Heald, Fowkes, Murray, Price, & 
Ankle Brachial Index, 2006; McDermott et al., 2005; Resnick et al., 2004). Although the as-
sociation met nominal levels of statistical significance, the magnitude of the association is 
small and is not considered to have practical implications for clinical practice, or of utility in 
predicting the presence of abdominal aortic dilatation.   
 Abdominal aortic aneurysms (anterior-posterior AAD of 3 cm or more) tend to coexist 
with peripheral atherosclerosis, and the prevalence of PAD in patients with abdominal aorta 
aneurysms varies between 9% and 40% (Axelrod et al., 2002; Hassen-Khodja et al., 1998; 
MacSweeney et al., 1993). The aforementioned large variation is due to the dissimilarities in 
the burden of atherosclerosis in the populations inducted into these studies. Not much is 
known about the association between ABI and AAD less than 3 cm. Our study was able to 
examine the association between ABI and AAD (across its ranges), and it documented a 
statistically significant association of small magnitude between ABI and AAD, which, howev-
er, has little clinical relevance in our assessment.  
The reported prevalence of AAAs (aortic diameters 2.9-4.9 cm) in men between 75-
84 years of age ranges between 1.3%-18.5% and between 1%-4.8% in women in the same 
age range (Boll et al., 1998; Go et al., 2013; Singh et al., 2001). For this report, participants 
were excluded if they had been diagnosed with AAA or undergone surgical repair for aortic 
dilatation prior to the examination. Consequently, AAD of 2.9 cm or more was rare and un-
der-represented in our study population (N = 39), limiting our ability to characterize the as-
sociation between ABI levels and larger abdominal aorta diameters.   
Abdominal aortic aneurysms are a health concern in that they are a condition of low 
prevalence but have unforeseen and often fatal outcomes. On a global scale, age-
standardized disability-adjusted life years (DALY’s) for AAAs in twenty-one different regions 
of the world have increased by an average of 3.6% from 1990 to 2010 (Murray et al., 2012). 
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Similarly, the global age-standardized death rate attributed to aortic aneurysms calculated 
from 187 different countries increased by 12.7% during the same period (Lozano et al., 
2012).   
There is controversy concerning the screening for AAAs. On the one hand, the prev-
alence of AAAs is low and the costs outweigh the benefits of screening on a population-
based level, while on the other hand the dire complications of AAAs warrant early detection 
to reduce morbidity and mortality. The U.S. Preventive Services Task Force (USPSTF) rec-
ommends that men between the ages of 65 and 75 who have a history of smoking undergo 
a one-time screening for AAA (strength of recommendation is grade B). The USPSTF also 
recommends offering selective screening to men between the ages of 65 and 75 who are 
non-smokers (strength of recommendation is grade C). The USPSTF further concluded that 
current evidence is insufficient to assess the benefits versus the harms of screening women 
between the ages of 65 and 75 who have a smoking history (strength of recommendation is 
grade I) (LeFevre & Force, 2014; "Summaries for patients. Screening for abdominal aortic 
aneurysm: U.S. Preventive Services Task Force recommendation statement," 2014).  
The recommendations by the USPSTF are similar to those by the American Heart 
Association. The AHA recommends selective screening for high-risk populations, which in-
cludes individuals with a family history of AAA and men of the ages 65 to 75 with smoking 
history (Hirsch et al., 2006). The above recommendations aim to decrease the morbidity and 
mortality in high-risk populations, although current screening recommendations do not im-
prove the survival rate for low-risk populations. Therefore, a search for a non-invasive and 
cost-effective tool that is able to indicate the presence of a dilated abdominal aorta remains 
a priority. This study found no evidence that ABI measurements are a promising approach to 
statistically predict increased abdominal aorta diameters in a population setting of low to av-
erage risk of AAA. Alternative or complementary strategies that consider biomarkers 
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(Folsom et al., 2015) or instrumentations that can index AAA or abdominal aorta dilatation 
may yet help to reduce the morbidity and mortality caused by AAAs.  
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Table 5. Characteristics of Study Participants at the 5th ARIC Cohort Examination (N = 4,802) 
Characteristic 
Mean ± SD 
N (%) 
Stratified by gender 
Mean ± SD, N (%) 
Stratified by race 
Mean ± SD, N (%) 
Male  
(n = 1,962) 
Female  
(n = 2,840) 
Black  
(n = 1,058) 
White  
(n = 3,744)  
Age, mean (years) ± SD 75.3 ± 5.1 75.6 ± 5.1 75.2 ± 5.04 74.5 ± 4.9 75.6 ± 5.1 
Body mass index, mean (kg/m2) ± SD 27.9 ± 4.5  28.03 ± 4.04 27.8 ± 4.8 29.2 ± 4.8 27.6 ± 4.4 
Female, N (%) 2,840 (59.1)     
African American, N (%) 1,058 (22.0)     
Current smoker, N (%) 275 (5.8) 117 (42.5%) 158 (57.5%) 72 (26.2%) 203 (73.8%) 
Current/former smoker (vs. never), N (%) 
(missing = 317) 
2,565 (53.4) 1,254 (48.9%) 1,311 (51.1%) 505 (19.7%) 
2,060 (80.3%) 
 
 
Pack-years 26.3 ± 22.5 30.6 ± 24.6 22.0 ± 19.1 18.6 ± 16.4 28.3 ± 23.3 
Diabetes*, N (%) (missing = 41) 1,440 (30.3) 658 (45.7%) 782 (54.3%) 425 (29.5%) 1,015 (70.5%) 
Hypertension†, N (%) (missing = 46) 3,450 (72.5) 1,372 (39.8%) 2,078 (60.2%) 909 (25.3%) 2,541 (73.7%) 
HTN Medication Use in Last 4 weeks, N (%)  
(missing = 9) 
3,686 (72.7)     
ABI  1.10 ± 0.14 1.13 ±0.15 1.09 ±0.12 1.04 ± 0.16 1.12 ± 0.13 
Proximal AP aorta diameters (cm) 1.95 ± 0.32 2.10 ± 0.32 1.85 ±0.28 1.90 ± 0.32 1.96 ± 0.32 
Mid-AP aorta diameters (cm) 1.81 ± 0.33 1.98 ± 0.35 1.69 ± 0.26 1.77 ± 0.32 1.82 ± 0.33 
Distal AP aorta diameters (cm) 1.70 ± 0.35 1.88 ± 0.38 1.58 ± 0.26 1.74 ± 0.32 1.70 ± 0.35 
Abbreviations:  ABI (ankle-brachial index); AP (anterior-posterior); SD (standard deviation); HTN (hypertension)   
* Diabetes: defined as present if glucose value ≥ 126 mg/dL or non-fasting glucose value ≥ 200 mg/dL or using medication for diabetes or self-
reported diagnosis of diabetes  
† Hypertension: defined as present if systolic blood pressure (mean of 2nd and 3rd measures) ≥ 140 mmHg or diastolic blood pressure (mean 
of 2nd and 3rd measures) ≥ 90 mmHg or medication is being taken for high blood pressure 
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Table 6. Percentile Values of Anterior-posterior Abdominal Aorta Diameters, by 
Location  (N = 4,802) 
Abdominal aorta diameter 
(cm) 
Percentiles 
 5% 10% 25% 50% 75% 90% 95% 99% 
Proximal anterior-posterior 1.5 1.6 1.7 1.9 2.1 2.3 2.5 2.7 
Mid-anterior-posterior 1.4 1.5 1.6 1.8 2.0 2.2 2.3 2.8 
Distal anterior-posterior 1.3 1.4 1.5 1.7 1.9 2.1 2.2 2.8 
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Figure 3. Anterior-posterior aortic diameter at proximal, mid- and distal an-
atomical locations, stratified by race and gender 
Box plot description: horizontal line within box represents the median, upper horizontal 
line of box is the 75th percentile, lower horizontal line of box is the 25th percentile, upper 
horizontal line outside the box is the 90th percentile, lower horizontal line outside the box 
is the 10th percentile, and circles represent outliers. 
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Figure 4. Ankle-brachial index stratified by race and gender   
Box plot description: horizontal line within box represents the median, upper 
horizontal line of box is the 75th percentile, lower horizontal line of box is the 
25th percentile, upper horizontal line outside the box is the 90th percentile, low-
er horizontal line outside the box is the 10th percentile, and circles represent 
outliers.  
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Table 7. β coefficients and 95% CIs for the Association of Anterior-posterior Proxi-
mal Abdominal Aortic Diameter with the Ankle-brachial Index 
 ABI ABI2 
 β coefficients  
[95% CI] 
p value β coefficients  
[95% CI] 
p value 
Model 1*  0.11 [-1.77, -0.74] < 0.0001 0.74 [0.49, 0.99] < 0.0001 
Model 2† 0.11 [-0.40, 0.61] 0.67 - 0.004 [-0.25, 
0.25] 
0.97 
Abbreviations: CI (confidence interval); ABI (ankle-brachial index) 
* Model 1 is adjusted for age. 
† Model 2 is additionally adjusted for age, race, gender, hypertension, smoking status, and diabe-
tes.  
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Figure 5. Scatter plot and best linear fit of anterior-posterior diameters 
of the proximal abdominal aorta vs. ankle-brachial index (ABI) of systol-
ic blood pressure 
Data points shown are age-adjusted predicted values from a regression model that 
includes ABI and its 2nd-order term. 
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CHAPTER 6: MANUSCRIPT 2- ARTERIAL STIFFNESS AS AN INDICATOR OF EN-
LARGED ABDOMINAL AORTA DIAMETERS. THE ATHEROSCLEROSIS RISK IN COM-
MUNITIES (ARIC) STUDY. 
6.1 Introduction  
 Among the biomarkers considered in the prediction of cardiovascular morbidity and 
mortality, arterial stiffening has emerged as a non-invasive measure of risk (Franklin, 2008; 
Mattace-Raso et al., 2006; Mitchell et al., 2010; Sutton-Tyrrell et al., 2005; Willum-Hansen et 
al., 2006). Arterial stiffening results from remodeling of the arterial wall with loss of elastin, 
coupled with increases in abnormal collagen (Johnson et al., 2001; Zieman et al., 2005). Ar-
terial stiffening occurs predominantly in the central arterial system with the aorta as a site of 
predilection, where arterial stiffening takes place to varying degrees at various segments 
due to inherent differences in the elasticity of the anatomic aortic segments (R. T. Lee & 
Kamm, 1994a).  
 The abdominal aorta is susceptible to aneurysmal dilatation, a diagnosed condition 
that is conventionally defined as an anterior-posterior diameter of the abdominal aorta of 3 
cm or more (Hirsch et al., 2006). The pathophysiology of aortic abdominal aneurysm (AAA) 
is complex and involves atherosclerotic changes and remodeling of the arterial wall, with 
increased production of collagen, loss of elastic fibers, and degradation of smooth cells that 
result in arterial stiffening (Ailawadi et al., 2003; Allison et al., 2008; Nordon et al., 2011; 
Raaz et al., 2014; P. K. Shah, 1997).  
 The clinical and public relevance of AAA lies in the unforeseen and dire complica-
tions associated with aneurysmal rupture. The overall mortality of patients with acute AAA 
who seek medical care can reach 70% (Basnyat, Biffin, Moseley, Hedges, & Lewis, 1999; 
Bown, Sutton, Bell, & Sayers, 2002; Verhoeven et al., 2008). Current screening guidelines 
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for AAA by the American Heart Association are selective and focus on older men with a his-
tory of smoking (Hirsch et al., 2006). 
 Identification of a non-invasive biomarker that is sensitive and specific in identifying 
individuals likely to have abdominal dilatation has the potential of reducing the mortality and 
morbidity associated with AAA. Given the involvement of arterial stiffening in the pathophys-
iology of abdominal aorta dilatation and AAA development, we posited an association be-
tween arterial stiffness and abdominal aorta diameter. Based on the literature indicating that 
pulse wave velocity (PWV) is a valid and reproducible measure of arterial stiffness (Chirinos, 
2012), we used PWV as a non-invasive surrogate for arterial stiffness in order to examine 
the association between PWV and the anterior-posterior diameters of the abdominal aorta at 
pre-specified anatomical sites in a population-based, biracial cohort of men and women ag-
es 70-89 years.  
6.2 Methods 
6.2.1 Study population  
 We conducted a cross-sectional analysis of data from the 5th examination of the Ath-
erosclerosis Risk in Communities (ARIC) study cohort (2011-2013) sponsored by the Na-
tional Heart, Lung, and Blood Institute (NHLBI). ARIC is a prospective epidemiologic study 
of adults aged 45-64 years at intake in 1987-89, drawn as probability samples from four U.S. 
communities (Washington County, Maryland; suburban Minneapolis, Minnesota; Jackson, 
Mississippi; and Forsyth County, North Carolina) ("The Atherosclerosis Risk in Communities 
(ARIC) Study: design and objectives. The ARIC investigators," 1989). The response rate for 
visit 5 was 65%, which represents 6,538 participants. Of those, 5,683 completed the meas-
urements include in these analyses. 
Of the 5,683 participants with a complete 5th exam, 1,459 were excluded from these 
analyses due to characteristics that may interfere with PWV measurements or due to miss-
ing observations. We excluded participants with missing abdominal aorta diameter (AAD), a 
 66 
body mass index (BMI) ≥ 40kg/m2, aortic stenosis, moderate or severe aortic regurgitation, 
aortic revascularization, peripheral revascularization, evidence of a major arrhythmia (Min-
nesota code 8-3-1) on a 12-lead electrocardiogram, and missing PWV values. Only white 
and African-American participants were included, since other race groups were not repre-
sented in numbers sufficient for analysis. The study was approved by the Institutional Re-
view Boards at each participating institution. Written informed consent was provided to the 
participants for each examination. After exclusions, our final analytical sample included 
4,224 participants.  
All measurements for the ARIC visit 5 were obtained by trained technicians following 
standardized protocols. Participants were asked to fast for 8 hours prior to their clinic visit 
and to avoid tobacco use and vigorous physical activity.  They were also asked to bring all 
medications (prescription and non-prescription) to the exam. Participants provided medical 
history and lifestyle information by completing interviewer administered questionnaires.  
Blood and urine specimens were obtained and shipped for assay and long term storage at 
three core laboratories. Anthropometric measurements, a standard 12-lead electrocardio-
gram, standing height measurement, body weight, and three seated blood pressure meas-
urements were obtained using an oscillometric automated sphygmomanometer (Omron Co., 
Ltd., Kyoto, Japan). Hypertension was defined as present if systolic blood pressure (mean of 
2nd and 3rd measures) ≥ 140 mmHg or diastolic blood pressure (mean of 2nd and 3rd 
measures) ≥ 90 mmHg or medication is being taken for high blood pressure. Diabetes was 
defined as present if glucose value ≥ 126 mg/dLor non-fasting glucose value ≥ 200 mg/dL or 
using medication for diabetes or a self report of physician-diagnosed diabetes. Details are 
available in Manual 2 (Home and Field Center Procedures) at 
https://www2.cscc.unc.edu/aric/cohort-manuals.  
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Abdominal aorta diameters  
Abdominal aorta diameter was measured by high resolution, real-time duplex ultra-
sound (Philips IE33). The participants were asked to fast for at least 8 hours prior to their 5th 
ARIC clinic visit as described above. To ensure data quality, the radiologists and certified 
technologists were trained to follow a standardized protocol. Transverse and anterior-
posterior diameters were measured at three pre-specified levels of the abdominal aorta: at 
the proximal aorta below the superior mesenteric artery, the mid aorta 2 cm below the renal 
arteries, the distal infrarenal aorta 1 cm superior to the aortic bifurcation, as well as the point 
of maximal abdominal aortic dilatation if not at one of the locations mentioned. Additional 
transverse images were taken in the case of a possible AAA (maximum diameter ≥ 2.8 cm). 
In this study, we focus on proximal anterior-posterior abdominal aorta diameters. Partici-
pants with a history of previous AAA repair or previous aortic bypass surgery for occlusive 
atherosclerotic disease were not scanned. Outliers equal to three standard deviations from 
the mean were excluded. 
Pulse wave velocity  
PWV measurements were performed using the automated non-invasive waveform 
analyzer VP-1000 Plus (Omron Co., Ltd., Kyoto, Japan) (Cortez-Cooper et al., 2003) follow-
ing a standardized procedure described previously (Meyer et al., 2016). Briefly, trained and 
certified technicians performed the measurement protocol while the participant was in the 
supine position with both arms resting along his/her side. Four size-appropriate blood pres-
sure cuffs were attached to both arms and ankles to record the systolic blood pressure and 
pressure pulse waves, respectively. A carotid sensor, a femoral sensor, and two electrocar-
diogram sensors were applied. Two measurements were taken to reduce process variability; 
the second measurement was obtained two to five minutes after the first measure.  A third 
measurement was performed if the study technician experienced difficulties in obtaining an 
optimal pulse wave form; technologists waited 2-5 minutes to obtain this measurement. The 
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average of the last 2 non-zero measurements was used. The distance between two arterial 
sites divided by the transit time was used to estimate PWV. The segments examined in this 
report are heart-carotid PWV (hcPWV), carotid-femoral PWV (cfPWV), and bilateral femoral-
ankle PWV (faPWV).  
6.2.2 Statistical analysis  
 We examined the distribution and calculated the means and standard deviations of 
PWV and AAD in the ARIC cohort at visit 5. We then characterized the strength and shape 
of the association between PWV segments and AAD across the range of PWV values. As-
sociations were characterized based on the continuous forms of PWV and AAD for inclusion 
in the final statistical model, as they best captured the association.  
Participant characteristics were estimated as means and standard deviations, medi-
ans and 25th and 75th percentiles, or frequencies and percentages, where appropriate. We 
examined the role of age, gender, race, cigarette smoking, elevated blood pressure, and 
diabetes mellitus as covariates and possible effect modifiers of the association between 
PWV segments and AAD. We performed bi-variable analyses between the aforementioned 
covariates and both AAD and PWV segments. The covariates statistically associated (p < 
0.05) with both AAD and PWV segments were adjusted for in Models 2,4, 6, and 8.   Model 
1 was adjusted for age to assess the ability to statistically predict proximal AAD from 
hcPWV. Model 2 included adjustment for age, gender, race, elevated blood pressure, diabe-
tes, and smoking to assess the ability of hcPWV to statistically predict proximal AAD. Model 
3 was adjusted for age to assess the ability to statistically predict proximal AAD from cfPWV. 
Model 4 was adjusted for age, gender, race, diabetes, and hypertension to assess the ability 
to statistically predict proximal AAD from cfPWV. Model 5 was adjusted for age to assess 
the ability to statistically predict proximal AAD from right faPWV. Model 6 was adjusted for 
age, race, smoking status, and diabetes to assess the ability to statistically predict proximal 
AAD from right faPWV. Model 7 was adjusted for age to assess the ability to statistically 
 69 
predict proximal AAD from left faPWV. Model 8 was adjusted for age, race, smoking status, 
and diabetes to statistically predict proximal AAD from left faPWV. Due to the very small 
magnitude of association between PWV segments and AAD we calibrated PWV segments 
to one standard deviation throughout our modeling steps.  
The analytical steps were repeated to examine the association between PWV with 
mid-anterior-posterior AAD and distal anterior-posterior AAD. To optimize model fit, we ex-
amined the improvement in model diagnostics by adding quadratic and third-order terms for 
PWV. All statistical tests are 2-sided, with a nominal significance level of P < 0.05. All anal-
yses were performed using Stata, version 14.0 (StataCorp LP, College Station, TX). 
6.3 Results 
Altogether, 4,224 ARIC visit 5 participants met our criteria for inclusion in the analy-
sis. The mean age was 75.3 ± 5.1 years and the mean BMI was 27.9 ± 4.5 kg/m2. The ma-
jority of the participants were women (60.4%), 22.7% were African-American, 52.6% 
were/are smokers, 29.4% were diabetics, and 71.3% were hypertensive (Table 8).   
The overall mean values for the PWV segments were; 1,132.8 ± 344.5 cm/s for 
hcPWV, 1,159.5 ± 302.7 cm/s for cfPWV, 1,099.2 ± 180.8 cm/s for right faPWV, and 1,067.8 
± 174.8 cm/s for left faPWV. The distribution of PWV varied slightly (less than one standard 
deviation) across gender and race (Table 8). The overall mean and standard deviation for 
proximal, mid-, and distal anterior-posterior AAD were 1.94 ± 0.31 cm, 1.80 ± 0.33 cm, and 
1.70 ± 0.33 cm, respectively (Table 8). AAD was smaller among women compared with 
men, and there were no apparent differences by race (Figure 6). The median values for an-
terior-posterior AAD at proximal, mid- and distal locations were 1.9 cm, 1.8 cm, and 1.7 cm, 
respectively (Table 9). The overall mean for PWV segments were 1,132.8±344.5 cm/s for 
hcPWV, 1,159.5 ± 302.7cm/s for cfPWV, 1,099.2 ± 180.8 cm/s for right faPWV, and 1,067.8 
± 174.8 cm/s for left faPWV. The distribution of PWV varied slightly (less than one standard 
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deviation) across gender and race (Table 8). The covariates retained in the regression mod-
els varied by each PWV segment and are shown in Table 3. 
A linear fit best described the association between hcPWV and AAD. The estimates 
of association and (95% confidence intervals) between proximal anteroposterior AAD and 
hcPWV, adjusting for age and gender, were 0.02 cms/s (0.02, 0.03), p < 0.0001). The fitted 
scatter plot for the association between hcPWV and proximal anteroposterior AAD is linear, 
showing a gradual increase in the AAD as hcPWV increases (Figure 7). The estimated 
mean and (95% confidence intervals) for proximal anteroposterior AAD in a 75 year old par-
ticipant (median age for study cohort) for hcPWV at the 25th (903 cm/s), 50th (1061.3 cm/s), 
and 75th (1282.5 cm/s)   percentiles is; 1.91 cm (1.90, 1.92), 1.93 cm (1.92, 1.94), and 1.97 
cm (1.96, 1.98) respectively.  
In a fully adjusted model (Table 10), the estimates were about the same. The pattern 
of association was similar between hcPWV and distal anterior-posterior AAD. 
Carotid-femoral PWV exhibited a weaker association with aortic diameter that was 
confined to the proximal AAD. The estimates of association and (95% confidence intervals) 
for cfPWV and cfPWV squared, adjusting for age and gender, were 0.06 (0.01, 0.1) and  
-0.01 (-0.02, -0.004), respectively. Significant P values (< 0.05) for both cfPWV and cfPWV 
squared indicate non-linear associations between cfPWV and AAD. 
Right and left faPWV were weakly associated with AAD only at the proximal level. 
The estimates of association and (95% confidence intervals) were 0.01 (0.001, 0.02) for 
right faPWV and 0.01 (0.003, 0.02) left faPWV, adjusting for age and gender; both P values 
were (>0.05). None of the covariates specified a priori (see above) reached nominal statisti-
cal significance (P ≤ 0.05) as effect measure modifiers on the association between PWV 
segments and AAD.  
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6.4 Discussion  
To our knowledge, this is the first report on the association between central and pe-
ripheral arterial stiffness and AAD in a biracial, population-based cohort of older men and 
women. Our results indicate that only hcPWV is associated with anterior-posterior ab-
dominal aorta diameter throughout its segments: the greater the value of hcPWV, the great-
er the AAD at the proximal, mid-, and distal locations. Although the association met nominal 
statistical significance, the magnitude of the association is small and not clinically meaning-
ful or useful in clinical practice to indicate the presence of abdominal aortic dilatation.   
 Heart-carotid pulse wave velocity is not widely used to measure arterial stiffness but 
was of interest in this study because it estimates stiffness from the carotid artery to the as-
cending aorta and excludes the abdominal aorta, our exposure of interest. Exclusion of the 
abdominal aorta is crucial since arterial stiffness measured by PWV takes into account the 
arterial wall properties such as the wall thickness to lumen diameter ratio. This relationship 
is best described by the Moens–Korteweg equation, PWV=  	  , where h represents wall 
thickness, Einc Young’s modulus of the arterial wall (stress/strain ratio), D arterial diameter, 
and 
 blood density (Chirinos, 2012).   Measurements of cfPWV are thus not independent of 
AAD and as a result are to some degree biased. This has been shown in a comparison of 
cfPWV before and after endovascular repair in patients diagnosed to have AAA. cfPWV was 
consistently higher before aneurysmal repair and lower 4 weeks after surgery (C. W. Lee et 
al., 2013a). 
It has been reported that hcPWV can indicate the presence of central atherosclerotic 
changes in hypertensive individuals (C. Li et al., 2015), but we are not aware of prior studies 
of hcPWV as an indicator of abdominal aorta dilatation. We are thus unable to compare our 
results to other estimates of the association between central arterial stiffness measured by 
hcPWV and AAD. Nonetheless, the association between AAD and the elastic properties of 
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aortic segments has been addressed with other imaging modalities (Kadoglou et al., 2012; 
Kroner et al., 2013; C. W. Lee et al., 2013a; Nollen, Groenink, Tijssen, Van Der Wall, & 
Mulder, 2004; Vande Geest, Sacks, & Vorp, 2006), and the available evidence predominant-
ly supports an association of AAD with central arterial stiffness (Kadoglou et al., 2012; 
Kroner et al., 2013; Luo, Fujikura, Tyrie, Tilson, & Konofagou, 2009; Nollen et al., 2004; 
Raaz et al., 2015; Vande Geest et al., 2006). Furthermore, human aneurysmal and non-
aneurysmal abdominal aorta tissue specimens were compared with biaxial tensile testing to 
evaluate arterial stiffening and extensibility (Vande Geest et al., 2006). The aneurysmal tis-
sue exhibited higher levels of circumferential stiffness and lower extensibility compared to 
the normal abdominal aorta tissue (Vande Geest et al., 2006).  
The specificity of regional PWV measured by magnetic resonance imaging (MRI) in 
detecting the absence of aortic diameter growth has been estimated to be 78%, and its sen-
sitivity did not exceed 33%, based on a two-year longitudinal study (N = 47) that examined 
the diagnostic accuracy of regional PWV measured by MRI in predicting luminal growth of 
the aorta (Kroner et al., 2013). The ability of regional PWV to predict the absence of aortic 
luminal growth differed by aortic segment: The specificity at the abdominal aorta segment 
was 90% for the suprarenal segment and 83% for the infrarenal segment (Kroner et al., 
2013). In another longitudinal study (N = 78), participants were followed for approximately 6 
years and aortic diameter, aortic distensibility, and aortic stiffness were evaluated by MRI 
(Nollen et al., 2004). Aortic stiffness assessed by flow wave velocity did not significantly 
change during follow-up, but local aortic distensibility predicted aortic dilatation. Aortic dis-
tensibility was a stronger predictor for the ascending thoracic aorta than it was for the ab-
dominal aorta  (Nollen et al., 2004). 
Examination of the association between arterial stiffness and AAD in murine models 
led to the conclusion that the pattern and speed of pulse wave propagation varies between 
non-aneurysmal specimens and those with induced AAA (Luo et al., 2009; Raaz et al., 
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2015). Induced aneurysmal specimens exhibited a non-uniform movement of pulse waves 
through the aneurysmal wall, while the pulse waves moved uniformly through normal ab-
dominal aortic segments (Luo et al., 2009). The development of artificially induced ab-
dominal aneurysms in mice also revealed that stiffening gradually increases in the segment 
targeted to artificially induce AAA (Raaz et al., 2015).    
Peripheral arterial stiffness measured by faPWV was mostly not associated with AAD 
in our study. This may be explained by the arterial wall composition in the peripheral arterial 
system. Its greater density of smooth muscle tissue than that of the central arterial tree ren-
ders the peripheral arterial system less prone to arterial stiffening (Bezie et al., 1998; Fischer 
& Llaurado, 1966; Laurent et al., 2006).  
As a limitation of the results presented here, it should be noted that individuals were 
excluded from this study if they had been diagnosed with AAA or undergone surgical repair 
for aortic dilatation prior to the examination. Consequently, enlarged aortic diameters, such 
as AAD of 2.9 cm or more, were under-represented in our study population, limiting our abil-
ity to characterize the association between arterial stiffness and larger abdominal aorta di-
ameters.   
Abdominal aortic aneurysms are a condition of low prevalence but are often unde-
tected and have unforeseen, life-threatening consequences. The reported prevalence of 
AAAs (aortic diameters 2.9-4.9 cm) ranges between 1.3%-18.5% among men 75-84 years 
of age and between 1%-4.8% among women in the same age range (Boll et al., 1998; Go et 
al., 2013; Singh et al., 2001). On a global scale, age-standardized, disability-adjusted life 
years (DALY’s) for AAAs in twenty-one regions of the world increased by an average of 
3.6% (from 44/100,000 to 46/100,000) from 1990 to 2010 (Murray et al., 2012). Although the 
age-standardized death rates from 1990 to 2010 decreased by 12.7% (from 3.3/100,000 to 
2.9/100,000), the percentage of deaths attributed to aortic aneurysms in 187 countries in-
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creased by 45.3% (from 3986.3 to 3776.3 deaths of all ages) during the same period 
(Lozano et al., 2012) as an indication of the case fatality of this condition.   
The merits of screening for AAAs continue to be debated, given the low prevalence 
and high costs that ostensibly outweigh the benefits of screening at the population level. On 
the other hand, the dire complications of AAAs warrant early detection to reduce morbidity 
and mortality. The U.S. Preventive Services Task Force (USPSTF) recommends that men 
between the ages of 65 and 75 who have a history of smoking undergo screening for AAA 
(strength of recommendation is grade B). The USPSTF also recommends offering selective 
screening to men between the ages of 65 and 75 who are non-smokers (strength of recom-
mendation is grade C). The USPSTF further concluded that the current evidence is insuffi-
cient to assess the benefits versus the harms of screening women between the ages of 65 
and 75 who have a smoking history (strength of recommendation is grade I) (LeFevre & 
Force, 2014; "Summaries for patients. Screening for abdominal aortic aneurysm: U.S. 
Preventive Services Task Force recommendation statement," 2014).  
The recommendations by the USPSTF are similar to those by the American Heart 
Association (AHA). The AHA recommends selective screening for high-risk populations, 
which includes individuals with a family history of AAA and men between the ages 65 to 75 
who have a smoking history (Hirsch et al., 2006). The above recommendations aim to de-
crease the morbidity and mortality in high-risk populations; current screening recommenda-
tions would not improve the rate of AAA complications for low-risk populations. Therefore, a 
search for non-invasive and cost effective tools that indicate the presence of a dilated ab-
dominal aorta remains a priority. This study found no evidence that measures of central ar-
terial stiffening are a promising approach to index a greater likelihood of increased ab-
dominal aorta diameters in a population setting of low-to-average risk of AAA.     
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Alternative or complementary strategies that consider biomarkers (Folsom et al., 2015) or 
non-invasive measurement modalities that can index AAA or abdominal aorta dilatation may 
yet help to reduce the morbidity and mortality caused by AAAs.  
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Table 8. Characteristics of Study Participants at the 5th ARIC Cohort Examination (N = 4,224) 
Characteristic Mean ± SD 
N (%) 
Stratified by gender 
Mean ± SD, N (%) 
Stratified by race 
Mean ± SD, N (%) 
  Male  Female Black White  
Age, mean (years) ± SD 75.3 ± 5.1  75.4 ± 5.1  75.21± 5.03  74.5 ± 5.0  75.6 ± 5.0 
Body mass index, mean (kg/m
2
) ± SD 27.9 ± 4.5   27.9 ± 3.9  27.7 ± 4.8  29.1 ± 4.8  27.4 ± 4.3 
Female, N (%)  2,553 (60.4)         
African American, N (%)  957 (22.7)         
Current smoker, N (%)  275 (5.8)  117 (42.5%)  158 (57.5%)  72 (26.2%)  203 (73.8%) 
Ever-smoker, N (%) (missing = 275)   2,222 (56.3)  1,062 (47.8%)  1, 160(52.2%)  506 (19.7%)  2,060 (80.3) 
Pack-years (missing = 2,204)  25.8± 22.0  30.2± 24.3  21.4 ± 18.4  18.0 ± 16.1  27.8±22.9 
Diabetes*, N (%) Lower cutpoint 126 mg/dL  
(missing = 37)  
 1,243 (29.4)  557 (44.8%)  686 (55.2%)  380 (30.6%)  863 (69.4%) 
Hypertension†, N (%) >= 140 (missing = 39)  3,013 (71.3)  1,160 (38.5%)  1,853 (61.5%)  816(27.1%)  2,197 (72.9%) 
HTN medication use in last 4 weeks, N (%)  3,028 (71.7)         
hcPWV cm/s  1,132.8 ±344.5  1,256.7±382.9  1,051.8±289.5  1,147.5±350.7  1,128.6±342.6 
cfPWV cm/s  1,159.5 ±302.7  1182.03±307.1 1144.3±298.8  1228.8±333.9  1139.03±289.7  
Right faPWV cm/s  1,099.2±180.8  1098.2±183.2 1099.9±179.2   1052.9±179.5 1112.9±178.9  
Left faPWV cm/s  1,067.8±174.8  1066.9±176.3 1068.4±173.8   1030.4±171.4 1078.9±174.3  
Proximal aorta diameters (cm)  1.94 ± 0.31  2.10 ± 0.32  1.85 ±0.27  1.90 ± 0.32  1.96 ± 0.32 
Mid-aorta diameters (cm)  1.80 ± 0.33  1.98 ± 0.34  1.69 ± 0.26  1.78 ± 0.32  1.81 ± 0.33 
Distal aorta diameters (cm)  1.70 ± 0.33  1.87± 0.36  1.58 ± 0.26  1.74 ± 0.32  1.70 ± 0.34 
Abbreviations:  AP (anterior-posterior); SD (standard deviation); HTN (hypertension); hcPWV (heart-carotid pulse wave velocity); cfPWV (ca-
rotid-femoral pulse wave velocity); faPWV (femoral-ankle pulse wave velocity)    
* Diabetes: defined as present if glucose value ≥ 126 mg/dLor non-fasting glucose value ≥ 200 mg/dL or using medication for diabetes or 
self-reported diagnosis of diabetes  
† Hypertension: defined as present if systolic blood pressure (mean of 2nd and 3rd measures) ≥ 140 mmHg or diastolic blood pressure 
(mean of 2nd and 3rd measures) ≥ 90 mmHg or medication is being taken for high blood pressure 
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Table 9. Percentile Values of  Anterior-posterior Abdominal Aorta Diameters, by Loca-
tion  (N = 4,224) 
Abdominal aorta diameter 
(cm) 
Percentiles 
 5% 10% 25% 50% 75% 90% 95% 99% 
Proximal anterior-posterior 1.5 1.6 1.7 1.9 2.1 2.3 2.5 2.7 
Mid-anterior-posterior 1.4 1.5 1.6 1.8 2.0 2.2 2.3 2.8 
Distal anterior-posterior 1.3 1.4 1.5 1.7 1.9 2.1 2.2 2.8 
Figure 6. Anterior-posterior aortic diameter at proximal, mid- and distal 
anatomical locations, stratified by race and gender   
Box plot description: horizontal line within box represents the median, upper horizon-
tal line of box is the 75th percentile, lower horizontal line of box is the 25th percentile, 
upper horizontal line outside the box is the 90th percentile, lower horizontal line out-
side the box is the 10th percentile, and circles represent outliers.  
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Table 10. β Coefficients and 95% CIs for the Association of Anterior-
posterior Proximal Abdominal Aortic Diameter with Heart-carotid, Carot-
id-Femoral, and Femoral-Ankle Segments of Pulse Wave Velocity 
 β coefficients [95% CI] p value 
hcPWV   
Model 1*  0.02 [0.02, 0.03] < 0.0001 
Model 2** 0.03 [0.02, 0.04] < 0.0001 
cfPWV   
Model 3† 0.06 [0.01, 0.1] 0.02 
Model 4†† 0.07 [0.01, 0.1] 0.01 
Right faPWV   
Model 5¥ 0.01 [0.001, 0.02] 0.03 
Model 6¥¥ 0.01 [0.001, 0.02] 0.03 
Left faPWV   
Model 7€ 0.01 [0.003, 0.02] 0.01 
Model 8€€ 0.01 [0.005, 0.02] 0.003 
Abbreviations: CI (confidence interval); PWV (pulse wave velocity); hcPWV (heart-
carotid PWV); cf (carotid-femoral PWV); and faPWV (femoral-ankle PWV)  
All β coefficients are calibrated to one standard deviation (SD), and the SD for 
hcPWV, cfPWV, right faPWV, and left faPWV are, respectively, 344.5, 302.7, 
180.8, and 174.8.  
* Model 1 is adjusted for age. 
**Model 2 is adjusted for age, gender, and smoking status.  
† Model 3 is adjusted for age.  
†† Model 4 is adjusted for age, gender, race, diabetes, and hypertension.  
¥ Model 5 is adjusted for age.  
¥¥ Model 6 is adjusted for age, race, smoking status, and diabetes.  
€ Model 7 is adjusted for age. 
€€ Model 8 is adjusted for age, race, smoking status, and diabetes. 
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Figure 7. Scatter plot and best linear fit of anterior-posterior diameters of 
the proximal abdominal aorta vs. heart-carotid pulse wave velocity 
(hcPWV).  
Data points shown are age-adjusted predicted values from a linear regression model 
that includes hcPWV and age. 
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CHAPTER 7: MANUSCRIPT 3-THE ANKLE-BRACHIAL INDEX AND PULSE WAVE 
VELOCITY AS STATISTICAL PREDICTORS OF AAD  
This study set out to assess ABI and/or PWV as correlates of abdominal aorta diam-
eter and to derive risk equations to predict the presence of AAD for potential use in clinical 
settings and population research. Our plan was to develop a parametric binomial model 
from the best predictors (variables) of abdominal aortic diameter. Based on the small magni-
tude of the associations between ABI and PWV and AAD, there is insufficient justification to 
proceed to develop risk prediction equations. Such predictive risk models would likely 
achieve a good fit but poor discrimination and suboptimal classification performance. Their 
usefulness and clinical applicability would therefore be questionable. Thus, Aim 3 was 
deemed not applicable for ABI and PWV.  
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CHAPTER 8: DISCUSSION  
8.1 Recapitulation of overall specific aims 
 This dissertation examined peripheral arterial disease as an indicator of abdominal 
aorta diameter in a large bi-raccial, population-based study of older adults. It also examined 
arterial stiffness as an indicator of abdominal aorta diameter in this population. Due to the 
small magnitude of the association between both peripheral arterial disease and arterial 
stiffness with abdominal arterial diameter, we concluded that deriving risk equations to pre-
dict the presence of enlarged AAD would be of little clinical relevance.   
8.2 Discussion of results 
 This work documents the association between biomarkers of atherosclerosis and 
arteriosclerosis and abdominal aorta diameters. ABI and PWV were the biomarkers used to 
assess peripheral atherosclerosis and arteriosclerosis, respectively. We observed a statisti-
cally significant association between both ABI and PWV and AAD.  
 ABI, a biomarker of peripheral arterial disease, was used in this study to assess the 
strength of the association between ABI and AAD at proximal, mid-, and distal locations of 
the abdominal aorta. We observed a U-shaped relationship between ABI and AAD. This re-
lationship was consistent at all three locations of the abdominal aorta. Although this associa-
tion reached statistical significance, it was of small magnitude and thus not a good indicator 
of AAD. In the process of selecting the best fitting model, splines with nodal points at ABI 
values of 0.5 and 1.3 were examined; they did not improve model fit in comparison to the 
linear regression model with quadratic term for ABI.  Based on the literature a number of co-
variates were predefined as possible confounders and effect measure modifiers, including 
smoking, hypertension, diabetes, body surface area, gender, race, and age. A fully adjusted 
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model was fit including age, race, gender, hypertension, smoking, diabetes, and body sur-
face area, as well as one only adjusted for age, since it was not our purpose to account for, 
or partially explain the mechanisms behind the association between ABI and AAD.  
The associations observed in this population-based cohort have not been examined in simi-
lar large cohorts. Prior reports based on atherosclerosis-rich cohorts have examined the as-
sociation of peripheral arterial disease and abdominal aortic aneurysms and confirmed the 
coexistence of PAD and AAA to varying degrees (Allardice et al., 1988; Axelrod et al., 2002; 
MacSweeney et al., 1993). We believe that the generally healthy nature of the population in 
this study and the under-representation of dilated abdominal aortic diameters in these study 
participants contributed to the weak but statistically significant association of ABI and AAD 
that we observed.    
 As a manifestation of arteriosclerosis, arterial stiffness was examined in this study for 
its hypothesized association with AAD. We studied this association with AAD for both central 
and peripheral arterial stiffness, and we observed different associations. Heart-carotid PWV 
(hcPWV) and carotid-femoral PWV (cfPWV) are biomarkers of central arterial stiffness, and 
their association with AAD was examined separately. This work documented a monotonic 
and linear association between hcPWV and AAD throughout the three locations of the ab-
dominal aorta. A fully adjusted model was fit that included age, gender, smoking, and body 
surface area. Since it was not our purpose to account for, or partially explain any mecha-
nisms underlying an association between hcPWV and AAD we base our conclusions on a 
parsimonious model adjusted for age and gender. 
To our knowledge, no prior studies have examined the association of hcPWV and 
AAD. A number of reports that examined the association using different biomarkers of cen-
tral arterial stiffness are found in the literature, most of which support the association of cen-
tral arterial stiffness and dilated abdominal aorta diameter (Kadoglou et al., 2012; Kroner et 
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al., 2013; C. W. Lee et al., 2013b; Luo et al., 2009; Nollen et al., 2004; Raaz et al., 2015; 
Vande Geest et al., 2006).  
Carotid-femoral PWV is commonly used in studies to evaluate central arterial stiff-
ness (Laurent et al., 2006). In our study, we observed a statistically significant association 
between cfPWV and AAD at the proximal abdominal aorta, and as we moved distally the 
association ceased to meet nominal levels of statistical significance. Notably, the measure-
ment of PWV is in part dependent on the arterial diameter, as a result of which the estimat-
ed association between this segmental cfPWV measure and AAD is to some degree biased.   
Peripheral arterial stiffness was mostly not associated with AAD. Arterial stiffening 
occurs to a lesser degree in the peripheral arterial systems than in the central arterial sys-
tem (Laurent et al., 2006), reflecting inherent compositional differences between central and 
peripheral arteries (Bezie et al., 1998; Fischer & Llaurado, 1966). We believe that the com-
positional differences between the central and peripheral arterial system may explain the 
inconsistencies in the associations observed.   
Our aims were to characterize ABI and/or PWV as indicators of abdominal aorta di-
ameter and to derive risk equations predictive of the presence of dilated AAD. Given the 
small magnitude of the observed associations between both ABI and PWV and AAD, there 
was insufficient justification to proceed to the derivation of risk equations. 
In conclusion, this doctoral research demonstrated an association between both cen-
tral arterial stiffness and peripheral atherosclerosis and the abdominal aorta diameter. The 
magnitude of the association was small and therefore did not warrant the creation of a pre-
dictive risk model.  The search for other biomarkers or non-invasive measurement modali-
ties that can index dilated AAD may help reduce the mortality and morbidity caused by ab-
dominal aortic aneurysms.  
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8.3 Degree to which the goals of doctoral research have been met 
 Doctoral research is expected to demonstrate scientific depth, rigor, and to add to 
the current state of knowledge or clinical practice. The Epidemiology Academic Policies 
Manual identifies originality, depth, scholarship, and communication skills as the Depart-
ment’s standards for doctoiral research.  With the input of my advisor and committee mem-
bers, I submit that the doctoral research embodied in this dissertation and the manuscripts 
generated from it sufficiently address the four standards required by the Department. Origi-
nality was met through the novelty of the study questions examined. To our knowledge, this 
study is the first to examine arterial stiffness and peripheral arterial disease as indicators of 
AAD in a population based, biracial cohort. Thus, this study adds new knowledge about the 
association of both arterial stiffness and peripheral arterial disease and abdominal aorta di-
ameter.  
 The depth requirement was met through the investigation of two independent varia-
bles related to atherosclerosis and arteriosclerosis. In addition, a comprehensive and sys-
tematic analytical plan was followed to achieve the aims of this dissertation.  
 Scholarship was addressed through the comprehensive review of the state of the 
science and the rigorous process followed to complete this dissertation. The study questions 
were thoroughly examined and justified, and the available literature was studied in depth to 
gain adequate knowledge about the topic in hand.  
 Finally, the scientific writing skills requirement was met through the initial independ-
ent development of the two manuscripts, including the formulation of the rationale that puts 
the study question in context, describing the study design and methods used, summarizing 
the relevant results, and constructing a discussion section that describes the importance of 
the work done and relating it to the current state of knowledge. Once the initial manuscripts 
were formulated and distributed to committee members, I received substantive and editorial 
comments that were taken into account in finalizing them.  
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8.4 Strengths and limitations  
 The strengths of this study on the association between peripheral arterial disease 
and abdominal aorta dimeter and between arterial stiffness and abdominal aorta diameter 
include the novelty of the associations examined, the population-based nature of the study  
population, and the biomarkers used to evaluate PAD and arterial stiffness, which were es-
timated using an automated, validated, and reliable device. A further strength of the study 
lies in the large number of participants included in our analysis. This study includes more 
than 4,000 participants, a significant improvement over previous studies that have examined 
these biomarkers. . Also, the study population of older adults adds to relevance to the re-
sults, since the outcome of interest is more prevalent in this age group. Not least, the ARIC 
study conducted the examination by implementing standardized protocols and trained per-
sonnel to ensure data quality.  
 Several limitations of this study should be noted. The cross-sectional design pre-
vented us from assessing changes in AAD that may occur in concert with a change in ABI 
and/or PWV. The reliability of the ABI and hcPWV measures was estimated, and observed 
to be fair. Other limitations due to possible measurement error include estimating the dis-
tance for cfPWV by measuring the carotid-femoral length over the body, which may not be 
an accurate estimate of the corresponding arterial segment, and calculation of faPWV using 
height-based formulas validated only in Japanese populations. Lastly, dilated aorta diame-
ters are infrequent in this study population and may have resulted in underestimation of the 
magnitude of association.  
8.5 Future directions  
 Replication of this study in a population enriched with enlarged aorta diameters may 
serve to derive estimates of association more applicable to clinical settings. Also, longitudi-
nal studies that monitor the change of AAD associated with the change in ABI and or PWV 
would be desirable to better asses the nature and strength of the association between pe-
 86 
ripheral arterial disease and abdominal aorta dilatation and arterial stiffness and abdominal 
aorta dilatation. Further, other biomarkers may more accurately predict abdominal aorta di-
ameter, thus creating and opportunity for risk prediction to discriminate between normal and 
dilated abdominal aorta diameter.  
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